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Abstract

Background
Many who seek help for cognitive symptoms do not have, nor develop, dementia, and many described as having mild cognitive impairment do not progress to dementia. Nevertheless, subjective cognitive decline and mild cognitive impairment continue to be conceptualised as steps in the progression of degenerative brain disease towards dementia. Functional cognitive disorders (FCD), in which real and distressing symptoms result from potentially-reversible changes in brain function unrelated to pathophysiologically-defined disease, account for a proportion of those who do not follow this trajectory. 
Methods
We searched MEDLINE, EMBASE, and PsycINFO for observational studies of subjective cognitive symptoms that included data on ≥10 people with possible FCD published until 14th March 2019. We conducted a narrative review describing terminology, prevalence, and associations. 
Findings
Our review identified 251 studies. Symptom assessment methods were heterogeneous. Cognitive symptoms were common in the general population (30%, n=245,654). 24% of 12,003 individuals presenting to clinical services for cognitive disorders were defined as having subjective cognitive impairment, pseudodementia, or FCD.  These diagnoses were associated with affective symptoms, neuroticism, negative self-evaluation, and negative illness perceptions. Communication behaviours during clinical interactions discriminated functional from structural disorders. The risk of false positive biomarker profiles was noted. 
Interpretation
Cognitive symptoms are common. Around 24% of people presenting to memory clinics may have functional cognitive disorders. They are not ‘worried well’ but have psychiatric comorbidity and poor wellbeing. Research into markers of functional cognitive disorders is needed: to enable research into treatment, and to increase specificity of prodromal degenerative brain disease diagnoses.



Introduction
Increasing numbers of people seek help for memory problems, and yet many symptomatic patients attending memory clinics do not have degenerative brain disease, and do not progress to dementia.1,2 Cognitive symptoms or impairment may be caused by other medical and neurological disorders, or by prescribed or non-prescribed drugs, but the experience of cognitive failure can also arise through purely functional disturbances to cognitive and introspective processes. 
Functional cognitive disorders are a group of overlapping conditions in which cognitive symptoms are present which are genuine, distressing and often disabling, but experienced inconsistently and not related to systemic or brain disease (Box 1).3  They can be included under the umbrella of functional neurological disorders, one of the commonest causes of neurological disability.4,5 Although historically defined in terms of psychological stress and absence of disease, functional neurological disorders are now also understood in neurobiological terms, with evidence of dysregulated attention, sensorimotor prediction, self-agency, and emotional processing.6,7 Psychological stressors are no longer required for the diagnosis of functional neurological disorder, which, crucially, is only made on the basis of positive clinical features demonstrating characteristic internal inconsistency; misdiagnosis is rare.8 
Functional cognitive symptoms have received less research attention than other functional symptoms, although interest is developing. Teodoro et al. systematically reviewed the literature on “brain fog”, and cognitive symptoms in functional neurological disorders, fibromyalgia, and chronic fatigue syndrome, with the Teodoro paper suggesting a unifying theory in which excessive attention towards physical symptoms and cognitive processes generate symptoms.9 Bailey et al. systematically reviewed patterns of communication in memory clinics, identifying features with potential to discriminate between functional and neurodegenerative disorders: individuals with functional disorders were more likely to attend alone, to be worried about their memory, and to provide a detailed account of personal history and memory failures.10  However, despite increasing interest in identifying early prodromes of degenerative brain diseases, there has been no detailed examination of the prevalence and clinical associations of functional cognitive disorders (an important differential diagnosis) in the cognitive disorder literature. 
One reason for this may be that the scientific literature concerning functional cognitive disorders is a tangled landscape of overlapping terminology. Early 20th century physicians used the term ‘pseudodementia’ to describe a wide range of clinical syndromes with the appearance of dementia but rather caused by depression, conversion disorders (hysteria), dissociative states (including ‘Ganser states’), or disordered personality.11–13 The broader ‘pseudodementia’ concept has been superseded by ‘depressive pseudodementia’ – cognitive impairment associated with severe depression – although with better recognition of the frequency of depression and anxiety in prodromal degenerative brain disease, this clinical group remains aetiologically heterogenous. 
In recent years, researchers investigating subjective cognitive decline (SCD) have been strongly invested in identifying early clinical markers of neurodegenerative disease, rarely focusing on alternative causes of symptoms. People with subjective cognitive complaints but normal cognitive examination are sometimes described, unhelpfully, as ‘worried well’ (describing worry about experiences which fall within the range of normal, and which are not due to disease). Of equal concern, people with both subjective cognitive complaints and impairment on testing (therefore defined as having mild cognitive impairment (MCI)), or with subjective cognitive complaints and biomarkers suggestive of an underlying disease process, may receive life-changing predictions or diagnoses of dementia which are retained even when inconsistent symptom experience and subsequent cognitive trajectory are more consistent with a functional disorder.14  
There is an almost universal tendency in dementia research to view subjective cognitive symptoms as a preliminary to mild cognitive impairment and later dementia. However, an as-yet undefined proportion of those individuals with symptoms described in terms of subjective cognitive decline, subjective memory impairment, pseudodementia, or as the ‘worried well’, may be better described in positive terms as having the inclusively-generated diagnosis of functional cognitive disorders; challenging the prevailing SCD → MCI → dementia model. We aimed to systematically search and review the literature incorporating these diverse terms in order to assess the usage, prevalence and clinical associations of functional cognitive disorders in people with cognitive symptoms. 

Method
Search strategy and selection criteria
We conducted two simultaneous searches (A and B) of the published peer-reviewed English-language literature in MEDLINE, EMBASE, and PsycINFO databases to 14th March 2019, using the terms shown in Box 2. We included observational studies describing the cross-sectional diagnoses of those assessed for possible dementia in memory clinics or similar services; and observational studies, excluding treatment studies, which included (albeit not necessarily as a primary focus) original data on at least 10 adults (>18 years old) with subjective cognitive symptoms, arising de novo, who did not receive a diagnosis of dementia, delirium, or other medical or neurological causes of symptoms. Exclusion criteria (not applied to cross-sectional studies of memory clinics) were; primary diagnosis of (non-cognitive) functional neurological disorder, chronic fatigue syndrome, fibromyalgia, major psychiatric disorder other than depressive or anxiety disorders, or cognitive symptoms after physical illness or injury. The search, screening, and data extraction was performed by one author (LM). Data were synthesised into a narrative review. 

Results
Search results
Of the 251 included studies (Figure 1 and Supplementary Table A), 185 had a cross-sectional design, 61 longitudinal, and five described case series (≥ 10 people); 59 included at least one control group. 
Terminology
 A wide range of terms were used to describe non-dementia cognitive symptom profiles and diagnoses (Table 1).  
Population prevalence and outcomes
Prevalence of functional cognitive disorders in clinical settings
Thirty-nine studies (described in Table 2) described diagnoses in 40 clinical populations attending cognitive assessment services: all were in memory clinic (or similar) settings except for the earliest three: studies of in-patients investigated for suspected dementia, reflecting clinical practice at the time.15–17 The 39 studies included 13,637 people (57% female)), excluding Wright and Lindesay’s survey (N not reported).2,15,24–33,16,34–43,17,44–50,18–23 Studies used varying terminologies and reported varying degrees of descriptive detail. Of these 39 studies, 35 studies (n=13,353) reported dementia diagnoses in 54%, 32 studies (n=12,003) reported presence of clinical syndromes of subjective cognitive impairment, pseudodementia, or functional cognitive disorders in 24%, 30 studies (n=11,807) reported both functional cognitive disorder prevalence (24%) and dementia prevalence (53%) (Figure 2), and five studies (n=1,324) reported ‘no cognitive disorder’ in 47%. 
Cognitive disorders may also come to light during treatment of medical illness: of 166 medical in-patients  with severe acquired cognitive deficits suggestive of dementia (mean age 82·9), 8 (5%) were ultimately diagnosed with depressive pseudodementia.51 
Longitudinal outcomes in clinical populations 
If cognitive symptoms always represent steps on a trajectory towards dementia, every person with subjective cognitive impairment would be expected to progress to MCI, then dementia, with ongoing decline from the point of dementia diagnosis. Atypical trajectories (non-progressive, remitting, or fluctuating) are a potential marker of functional cognitive disorders. Although complete meta-analysis of the longitudinal outcome of subjective cognitive symptoms was outside of the scope of this review, we examined the included studies in order to consider whether, in broad terms, non-progressive cognitive problems were common or rare in those presenting for clinical assessment.
Three pre-1980 studies examined stability of dementia diagnoses. In Kendell’s study of the temporal stability of psychiatric diagnoses in 2000 patients first admitted to a psychiatric bed in 1964, dementia was the most stable of all psychiatric diagnoses at 77%; indicating, however, that 23% of those diagnosed with dementia severe enough to lead to hospital admission were ultimately re-diagnosed with something else.52 In another 10-year case-note review of 35 inpatients diagnosed with pre-senile (<65) dementia, 15 deteriorated as expected and 10 died, but 20 (57%) did not deteriorate but improved (n=18) or remained unchanged (n=2); revised diagnoses including depression (n=3), anxiety state (n=3), somatic symptoms without organic basis (n=6), and hysterical reaction (n=1), the authors stating that the non-progressors consisted mainly of 'people with marked personality difficulties and neurotic symptoms or affective disorder'.53 
Ten studies followed up clinical populations assessed at baseline as having subjective cognitive symptoms of uncertain or benign cause: none reported rates of progression to dementia greater than 10% during 2-4 year follow-up.54,55,64,56–63  If subjective cognitive decline was most often due to degenerative brain disease, it would be expected to be associated consequently with early death. However, two included studies reported no reduction in life expectancy in individuals with SCD over mean follow-up periods of 3·5 - 4 years.65,66
Poorer outcomes were reported in pseudodementia cohorts, both in terms of incident dementia and non-neurodegenerative mortality, although progression to dementia varied from 0-89%. Bulbena & Berrios followed up 22 individuals with pseudodementia (unipolar depression (n=10), bipolar disorder (n=5), psychosis (n=5), personality disorder (n=2), mean age 73·3) after 15-47 months; eight (36%) died, and of 14 survivors six (27%) developed dementia.67 Sachdev followed up 19 individuals with pseudodementia, (depression (n=8), bipolar depression (n=3) ,schizophrenia (n=5), mania (n=2), and schizophreniform disorder (n=1), mean age 53), over 12 years; eight (42%) died but none of the 11 (58%) survivors developed dementia.16,68 Kral & Emery, however, reported onset of dementia within eight years in 89% of 44 individuals with pseudodementia (mean age 76·5), despite initial resolution of affective and cognitive symptoms.69 Similarly, of 182 with depressive pseudodementia (mean age 78) followed up over 5-7 years, 71% developed dementia.70 
Schmidtke et al reported outcome in 46 of 73 individuals diagnosed with functional memory disorder (FMD) (mean age 55·2); 39 (85%) had persistent symptoms at mean follow-up of 20·1 months; symptoms had resolved in six (13%); one (2·1%) had dementia.71 Risk of incident dementia therefore was low (nonetheless present) but symptom persistence was the notable finding here, suggesting FMD is not a benign condition. 
Cognitive symptoms in the general population 
To understand who presents for clinical assessment, and why, it is important as a first step to estimate the general prevalence of cognitive symptoms. 
Fifty-six studies described prevalence of cognitive symptoms in community populations (Table 3), using a variety of assessment methods, finding symptoms in between 8% and 80%, with overall 30% of the 245,654 individuals included reported to have cognitive symptoms.72,73,82–91,74,92–101,75,102–111,76,112–121,77,122,123,78–81  
Of those cross-sectional studies including objective measures of cognitive function; 18 found a positive association between symptoms and objective impairment;72,73,94,102,106,109,122,124–126,74,75,79,82,83,90–92 though 14 did not.77,78,120,127–129,80,81,85,89,100,101,103,108 Some reported symptom association with impairment in subgroups: specific rather than global cognitive symptoms 86, SCD-plus (SCD with additional clinical or bio-markers suggesting neurodegenerative disease) but not SCD alone 107, and only in male participants.96 There was no correlation between prevalence of reported cognitive symptoms and mean study population age, although this must be interpreted with caution given the different measures used (Figure 3). 
Factors associated with help-seeking for cognitive symptoms
Having established in our first step that cognitive symptoms are common, in our second step towards understanding why people present with cognitive symptoms we identified seven studies reporting factors associated with seeking help for cognitive symptoms. 
Comparing self-referred with physician-referred memory clinic patients, self-referrers reported greater decline, had more depressive symptoms, more trait anxiety, higher estimated premorbid IQ, and were more likely to have had previous depression requiring treatment.130,131 Four other studies reported that help-seekers had poorer memory self-efficacy, quality of life, and were more often worried because of a family history of dementia,132 were more likely to perceive a biological or medical (rather than social) cause of memory problems,133 and had more depressive symptoms and hippocampal atrophy than symptomatic non-help-seekers  despite similar cognitive scores, anxiety scores, and cerebral amyloid deposition.134  Haussman found that intrinsic motivation – attending because of self rather than others – reduced likelihood of dementia diagnosis.135 In Tsoi’s Ganser syndrome study, every presentation was assessed to be motivated by external circumstances, including avoidance of murder trial, head injury compensation, and ‘dissatisfaction with army life’.136  
In summary, those seeking help for subjective cognitive symptoms are more likely to be distressed, depressed, anxious, and to be more concerned than others about their memory; they cannot be considered ‘worried well’.  It is possible that a significant proportion have functional cognitive disorders (Box 1).
Longitudinal outcome of cognitive symptoms in the general population 
Comprehensive meta-analysis of longitudinal outcomes was outside of the scope of this review, but we aimed to summarise the range of outcomes in included studies in order to consider broadly whether cognitive symptoms, in those who do not necessarily seek help, frequently or infrequently progress to dementia. 
Twenty-six studies reported outcomes in non-clinical populations with subjective cognitive symptoms after between one and ten years. In 13 elderly cohorts, baseline subjective cognitive symptoms were associated with increased risk of future cognitive decline, although in studies reporting incident dementia rather than decline on cognitive tests, numbers progressing to dementia were small: at most 11% (over 7 years, in Reisberg et al.) of any individual study population. 75,79,141–143,82,83,92,118,137–140 Two studies, in 453 individuals (mean age 80·5) and 1990 (mean age 80·1), reported increased risk of progression in stable but not unstable (relapsing and remitting) SCD 126,144 Amariglio et al. found symptoms predictive of decline only in individuals with amyloid positive profiles on PiB-PET in a cohort of 279 (mean age 73·7).145 In a cohort of 1416 (mean age 75·3), SCD no longer predicted decline after adjusting for baseline cognitive performance.79  Six studies (all mean age >65) reported that symptoms did not predict future decline.64,77,125,146–148 Three studies described predictors of future increases in cognitive symptoms: low control beliefs (corresponding to low or external locus of control),149 female sex, fear of falling, anxiety and depression,150 and longitudinal change in cognitive performance.151  
In summary, and in keeping with systematic reviews assessing this specific question,152 while some individuals with subjective cognitive symptoms progress to dementia, the majority (around 90%) do not. 
Reported associations between clinical variables and functional cognitive disorders
We hypothesise that a significant proportion of those with subjective cognitive symptoms in clinical populations have functional cognitive disorders, and summarise below reported clinical associations. In including biomarker studies, we intended not to assess the predictive value of these biomarkers per se, but rather to consider the clinically important question of what patterns of results might be found in those with functional cognitive disorders.  
Structural Neuroimaging
As cerebral atrophy is a key marker of degenerative brain disease, and medial temporal lobe atrophy a marker of AD, functional cognitive disorders (assumed here to represent many of those with subjective cognitive symptoms) might be expected to be associated with an absence or relatively small degree of atrophy. Several included studies confirmed this: finding degree of global atrophy unrelated to measures of cognitive function in individuals complaining of memory loss153 or to symptom severity,154 and three studies reported no difference in brain volume between groups with subjective memory complaints and healthy controls.155–157 Two studies reported greater medial temporal volumes in depressive pseudodementia than AD, and one reported greater hippocampal volumes in subjective cognitive impairment than AD or MCI.158–160 One study defined a ‘non-neurodegenerative’ subjective memory impairment subtype  with minimal atrophy.161 
Five studies, however, reported smaller hippocampal volumes in subjective memory impairment compared with healthy controls, reporting smaller hippocampi in less-depressed SMI,162 in SMI with AD family history,163 and, in Perrotin et al., in association with help-seeking.134,155,159,164 A study of ‘dementia syndrome of depression’ reported atrophy intermediate between unimpaired depressed individuals and those with AD.165 In 60 memory clinic patients (mean age 72·6) white matter lesion severity correlated with subjective memory symptoms and depression severity.166 Superior temporal gyrus atrophy correlated with depressive symptoms in unaccompanied memory-clinic attenders, the authors proposing that depression was the cause of atrophy, rather than the result.167 
Just as the absence of atrophy cannot exclude degenerative disease, the presence of atrophy is not specific: a study describing an ‘AD-like’ atrophy pattern present in 13% of those with SMD reported that 27% symptomatic individuals with this pattern did not progress within 90 months. 168
Functional Neuroimaging
Functional MRI
Rodda et al. reported increased fMRI activation in the left medial temporal lobe, bilateral thalamus, posterior cingulate and caudate in patients with subjective cognitive impairment compared with healthy controls.169 Kawagoe et al. described increased resting-state functional connectivity, related to symptom severity, in the lingual gyrus, anterior insula, and superior parietal lobe.154 The authors of both studies suggest the observations might reflect compensatory activity in early neurodegenerative disease. In contrast, Hu et al. described absent hippocampal activation during a choice-making task in people with SCD compared with controls.170 
Cerebral blood flow
A PET study of regional cerebral blood flow reported decreased flow in left anterior medial prefrontal cortex and increased flow in the cerebellar vermis in patients with major depression and significant cognitive impairment compared to depressed patients without cognitive impairment.171 Gucuyener et al. reported no differences in cerebral blood velocities as measured by transcranial doppler ultrasound between patients with depressive pseudodementia and AD controls, but impaired vasoneural reactivity to visual stimuli only in AD.172 
Metabolic Imaging
Amyloid Positron Emission Tomography (PET) 
If subjective cognitive symptoms often represented an AD prodrome, an association with increased cerebral amyloid deposition would be expected, although amyloid is not specific to AD.173 Five studies examined cerebral amyloid burden in subjective cognitive impairment or decline, using Pittsburgh B (PiB) or (18) F-florbetapir ligands. Results were mixed. One study reported no difference in amyloid between community SCI participants and healthy controls.156 Another reported more amyloid in clinical and community SCD participants than in healthy controls.134 Three studies examined amyloid in relation to cognitive symptoms, finding no association with global cognitive symptom scores, although Amariglio et al. reported a specific association with impaired memory and Perrotin et al. reported, somewhat tenuously, that although those with higher PiB uptake did not report inferior memory, they were less likely to report superior memory than others.150,174,175 Overall, therefore, of the five included amyloid PET studies, only Perrotin et al. reported a clear association with presence of subjective cognitive symptoms, reporting amyloid-positivity in 9% controls, 29% clinical and 34% community SCD participants.134 
Neurophysiological measures
The authors of two pre-1990 papers on pseudodementia and mixed depression and dementia described diagnostic use of electroencephalography (EEG): more often abnormal in AD.12,176 Hutton reported worse eye tracking in AD compared with pseudodementia and healthy controls.177 Examining the P300 late-evoked potential in passive listening and ‘oddball’ tasks, Gottlieb reported no difference between individuals with pseudodementia and healthy controls.178 Cespon et al. reported greater medial frontal negativity (a correlate of conflict monitoring) in those with higher levels of SMC.179 
Genetic variables
Prodromal (indeed, preclinical) AD would be expected to be associated with an increased risk of carrying the APOE ε4 allele, the most penetrant genetic risk factor for sporadic AD; but in keeping with systematic reviews of this specific question, five included studies of people with subjective memory symptoms found no increase in APOE ε4 allele prevalence.81,157,180–183 
Cerebrospinal fluid (CSF) ‘biomarkers’
One study found an ‘AD profile’ of CSF (pathological Aβ42:T-tau ratio) more frequent in SCI (52%) than in healthy controls (31%).56 Eckerstrom and Garcia-Ptacek found CSF biomarkers more frequently normal in SCI than in MCI or AD.160,184 Overall, therefore, those with subjective cognitive symptoms appear more likely to have pathological biomarkers than controls, but less likely than those with objective impairment; many described as having SCI do not have markers of degenerative brain disease.  
Six included studies reported outcomes of subjective cognitive symptoms in relation to CSF AD biomarkers. Visser reported that no SCI subjects progressed to dementia (including those with a pathological Aβ42:T-tau ratio) by 2·3 years.56 Van Harten reported that low Aβ42 alone (without abnormal tau) predicted progression in a clinical population with subjective complaints, but numbers were small: of 132 people with subjective complaints, ten had low Aβ42, of whom two (18%) declined over two years; in another cohort described by the same authors, 12 of 115 with subjective complaints had low Aβ42, of whom eight (62%) declined.59,60 Sierra-Rio reported that pathological Aβ42:p-tau ratio was associated with progression in SCD; but of 55, 11 had this profile of whom only three (27%) declined.185 
Overall, although CSF AD profiles may be slightly more common in SCD than in normal controls, the predictive value for any individual is uncertain; as eloquently demonstrated by a longitudinal study in which CSF biomarkers did not improve clinicians’ diagnostic or prognostic accuracy in suspected cognitive disorder; sensitivity was the same but specificity lower when CSF biomarker status was available, with most resulting false positive predictions, importantly, in those with subjective complaints only.186 
Neuropsychological test performance
Neuropsychological tests are a pre-requisite in all dementia diagnostic criteria. It is important to consider how those with functional cognitive disorders perform in such tests in order to understand when and how to use them in diagnosis. 
Thirteen studies examined neuropsychological test performance in subjective symptoms (a proportion of whom are likely to have functional disorders) in comparison with healthy, MCI, or dementia controls (Table 4):157,158,194–197,170,187–193 participants generally performed similarly to or worse than healthy controls, but better than MCI or dementia controls. 
Nineteen studies examined the relationship between subjective cognitive symptoms and objective cognitive performance (Table 5),154,166,204–212,175,193,198–203 ten reporting a relationship between symptom report and measured cognition in at least a subset of participants and nine finding no relationship. Where there was discord, memory complaint exceeded impairment. 
Three studies reported that neuropsychological tests had predictive value in subjective cognitive symptoms, reporting associations with decline at one, two, and seven years.55,213,214  However, while analysis of specific tests and ‘forgetting index’ in one study identified 79% of those with cognitive complaints converting to dementia within 5-6 years, this model therefore incorrectly predicted dementia in a significant 21%.215 Jansen et al. did not find that neuropsychological assessment improved dementia classification in 221 memory clinic attenders, increasing false positive predictions of decline in those with SCI.216 Overall, although mild baseline impairment seems more likely in those with degenerative brain disease, the predictive value of neuropsychological testing for any individual is inaccurate. 
Specific cognitive features were described in ten patients with Ganser syndrome: amnesia, approximate answers (‘vorbeigehen’ – incorrect answers which demonstrate knowledge of the correct answer), fugue or trance-like state and hallucinations.136 The approximate answer demonstrates internal inconsistency, and can be considered a (rarely described) positive sign of functional cognitive disorder. 
Validity tests also demonstrate internal inconsistency, although the utility of validity test failure in discriminating prodromal degenerative brain disease from functional disorders remains unclear. One study reported that 7% of 170 (13% of those under 65) memory clinic patients with MCI, ‘uncertain diagnosis’, or ‘worried well’ scored in a ‘noncredible’ range on the Word Memory Test and/or Test of Memory Malingering.217
Interactional and linguistic features
Some groups have examined interactional and linguistic features during the consultation. As clinical consensus was used as the ‘gold standard’ diagnosis in most studies, we note risk of diagnostic suspicion bias, in which clinicians may use the assessed features consciously or subconsciously to make the diagnosis. 
Eleven studies described observable differences in behaviour or language during the clinical assessment which discriminated functional cognitive symptoms to those due to degenerative brain disease (Table 6).38,48,225,226,167,218–224 Those with functional symptoms were reported to be more likely to attend independently, offer detailed descriptions of complaints and personal history, to produce a written list of complaints; they were less likely to exhibit the ‘head turning sign’ or otherwise rely on an accompanying adult.38,48,218–222,224–226
Cognitive symptom profile
We considered whether any specific cognitive symptoms increased the likelihood of a functional cognitive disorder. Wells reported that patients with pseudodementia reported memory loss for both recent and remote events (vs. relative remote memory preservation in early AD); memory gaps for specific periods or events; dated symptom onset precisely; and had symptoms of short duration and rapid progression.218 Ahmed et al. reported, in a two-year longitudinal study, that baseline complaints did not differ between ‘worried well’, amnestic MCI and semantic dementia.227 Haussman et al. found initial symptoms of attention deficit or word finding impairment more likely in those with SMI and normal objective cognition, compared with those with dementia, in whom first symptoms were more likely ‘unspecified’, memory impairment, or orientation deficit.135 
The use of symptom ‘checklists’ was described in two studies of cognitive impairment in depression: Reynolds et al. correctly classifying 90·5% (anxiety, delayed insomnia and loss of libido supporting pseudodementia diagnosis); Yousef et al correctly classified 98% of those with dementia and 95% of those with depression.228,229  
Metacognition 
As described, the included studies reported poor concordance between cognitive symptoms and measured performance. Metacognition can be defined as the process of or ability to monitor and evaluate one’s own thinking; discordance between memory self-report and performance representing metacognitive error. 
A small number of studies examined metacognitions in those with functional or subjective cognitive symptoms. Two studies of functional memory disorders found poorer memory self-efficacy (evaluation of one’s own ability) in patients compared with healthy controls.230,231 Larner found memory self-rating of ‘poor’ or ‘fair’ 0·87 sensitive but < 0·5 specific for functional cognitive disorder in memory clinic.49 Elsey et al. reported that those with functional memory disorder were more concerned about memory symptoms than their companions.219 Mogle et al. found higher memory ratings compared with others the same age associated with better psychological wellbeing.232 Chin et al. reported that, in those with normal cognitive testing, subjective memory symptom severity was associated with increased self-focused attention.208  
Illness perceptions
Three studies suggested that illness perceptions influence symptom severity. Negative ageing stereotypes were associated with more subjective memory complaints (and depressive symptoms), whereas factors contributing to ‘meaning in life’ were associated with fewer complaints.128,206 The impact of knowledge of genetic risk was explored by Lineweaver et al: participants informed of their APOE ε4 positive status rated their memory worse and performed worse than those who remained unaware that they were APOE ε4 positive.233 Hurt et al. reported that helplessness, illness identity, serious perceived consequences, emotional representation, and negative comparison with peers were strong determinants of distress and anxiety in adults with SMC.133 
Non-cognitive symptom profile
We examined reported associations between functional cognitive disorders and non-cognitive symptoms in order to consider whether a distinct phenotype could be defined in those with primary cognitive symptoms, having excluded studies of those with primary (non-cognitive) functional neurological disorder, chronic fatigue  syndrome, fibromyalgia, major psychiatric disorder other than depressive or anxiety disorders, or cognitive symptoms after physical illness or injury.
The most striking association was between depressive symptoms and cognitive symptom severity, in both clinical and community populations; anxiety symptoms and personality traits (particularly neuroticism) were also frequent associations (Table 7).12,67,193,195,196,198,201,202,204,205,208,209,128,218,231,234–241,130,242–251,131,252–256,134,166,167,181,184 Depressive symptoms were in some studies associated with objective cognitive impairment.198,237,247,257,258 Kawagoe et al. reported higher apathy scores in association with cognitive symptom severity.154 Cognitive symptoms were also reported to be associated with self-reported multimorbidity, 259 physical health complaints,238 more pain and analgesia use,260,261 and psychosomatic complaints as measured by SCL-90.230,231 Five studies reported an association between functional or subjective cognitive symptoms and reported stress.184,206,230,231,262 Three studies reported an association between SMC severity and more general measures of poor psychological wellbeing,119,187,232,259 two with poorer quality of life,189,263 and one qualitative study reported that presence of subjective memory symptoms had a variable impact on wellbeing.264 
Nine studies described sleep disturbance in association with functional cognitive symptoms. Reynolds et al. described more delayed insomnia, longer recording periods, early-morning waking and higher REM intensity in those with depressive pseudodementia compared to those with dementia.228,251 Self-report of poor-quality sleep was associated with symptoms in FCD, SMC without objective impairment or AD biomarkers, memory clinic ‘complainers’ without dementia, and in population cohorts with SMC or perceived decline. 39,46,257,262,265,266 However, in 181 adults (mean age 74), sleep actigraphy showed less sleep disruption in those with higher, compared with lower, complaint of subjective memory decline; the authors suggesting a ‘non-linear trajectory between sleep and memory decline in aging’. 267 An alternative explanation supported by the other studies identified would be that while sleep is more measurably disordered in degenerative brain disease, greater experience of disturbed sleep in those with functional cognitive disorders reflects differences in self-monitoring and expectation. 
Age 
Age is the most important risk factor for degenerative brain disease. If subjective cognitive symptoms were most often prodromal, a close relationship between symptom prevalence and advancing age would be expected, but this was not confirmed by the included studies. Rowell et al. reported that prevalence of SMC was similar across all age groups in 3,798 18-99 year olds, Derouesne et al. reported that of those self-referring to a memory clinic younger patients rated their symptoms as major and of longer duration, and Apolinario et al. similarly reported that younger patients (from an elderly cohort) reported a higher number of complaints.246,249,252 Sinforiani and Gallassi both reported that symptomatic patients without impairment tended to be younger, whereas Arbabi found no difference in age between impaired and unimpaired SMC.241,247,268 
Family history
Family history is a risk factor for degenerative brain disease; but experience of dementia in the family may also influence self-evaluation and help-seeking. Four studies examined memory symptoms in relation to family history of dementia: in McPherson et al. symptom report was similar overall, but relatives of people with early-onset AD reported worse memory than controls, correlating with impairment; in Rue et al. relatives had more memory complaints and depressive symptoms, explained as a possible mediator of slightly poorer performance; Cutler et al. found that although relatives were more concerned about developing AD, this concern was not reflected by memory self-ratings.269–271 Arbabi found no difference in family history between impaired and unimpaired patients with SMC.247 Bharambe et al. found higher rates of family history of dementia in memory clinic patients with functional cognitive disorder.50 Haussman et al. reported more subjective impairment in healthy adults with family history compared to without, an association not present in the MCI group,163 and Hill reported equivalent levels of SMI had a greater impact on emotional wellbeing in those with personal experience with dementia.264 
Discussion 
Cognitive symptoms are common: according to this review present in around a third of the population, with no clear relation to age. This alone confirms that that not all cognitive symptoms are caused by degenerative brain disease. In studies of people presenting to memory clinics, we found that only 55% received dementia diagnoses, and in studies including adequate description of diagnoses, 24% were described as having subjective cognitive impairment (with, or without primary psychiatric disorder), pseudodementia, functional cognitive disorder, or a primary psychiatric disorder,  and not degenerative brain disease or other medical cause. We consider it likely that many of these individuals could be described as having functional cognitive disorders (FCD).
A striking number of terms used to denote cognitive symptoms in the studies included here denoted only a few concepts: cognitive complaints without aetiological presumption (e.g. ‘subjective memory complaints’); perceived cognitive impairment in the absence of measured impairment or disease (‘worried well’, or ‘clinically/cognitively normal’); progressive symptoms (‘subjective cognitive decline’); and symptoms with positive evidence of non-degenerative cause (‘functional cognitive disorder’, ‘depressive pseudodementia’). As terminology varies, so do methods use to ascertain presence and severity of subjective cognitive symptoms: a significant limitation of this body of research is that even of those studies (see table 3) using the same terminology, few used the same measure, and even those using a single question address such various aspects – for example, perceived memory decline, poor memory compared with others, worry about memory, having a poor memory –that it seems unlikely that different studies are describing similar subjective experiences. Historical use of terms such as ‘pseudodementia’ introduces even more confusion, having been used to describe a wide range of clinical syndromes and aetiologies. 
The concepts implied by these terms are important. Authors of SCD and MCI studies tend to view these states as steps on a trajectory towards dementia, paying less attention to possible alternative causes. A dominant linear SCD → MCI → dementia trajectory is not supported by this review or by other, more comprehensive analyses of outcome, which instead suggest multiple overlapping symptom trajectories (Figure 4). In Jonker’s review of the relationship between memory complaints and dementia, complaints in the ‘young-old’ were most often related to ‘depression, anxiety, or personality factors’, predicting dementia only in a small subset.272 Reisberg et al’s description of a ‘robustly identifiable clinical entity’ lasting 15 years before progressing to MCI is at odds with the observed frequency of cognitive complaints in the general population and lack of excess mortality.65,66,273 While a systematic review reported increased risk of incident dementia in subjective cognitive impairment, 86% followed up beyond four years did not progress to dementia.274 Although not explored here, the prevalence of FCD in individuals meeting MCI criteria will be an interesting toping for future research: meta-analysis of MCI progression in 41 cohort studies found that most with MCI did not progress to dementia even after 10 years.275
With the ongoing dominance of the SCD → MCI → dementia model, aetiological assumptions have become attached to descriptive terms, limiting the range of interpretation of research findings. As examples: researchers finding an inverse relation between measured sleep quality and SCD severity suggest ‘a non-linear trajectory between sleep and memory decline‘, and researchers finding opposite patterns of resting state fMRI in SCD to those seen in AD hypothesise that these are compensatory responses to neurodegeneration: neither group considering that their findings might indicate functional, rather than AD, pathology.154,276,277 Although MCI is outside of the scope of this review, efforts to make results fit with the SCD → MCI → dementia model can be seen in studies of AD biomarkers in individuals with MCI, where profiles associated with mildly increased risk (for example, 11% vs 6% over seven years)278 are described as predictive, with little discussion of the frequency or clinical significance of false positives, when meta-analyses of the same biomarkers report poor accuracy.173,279–282 For example, review of 11C-PIB-PET as a predictor of MCI conversion to dementia reported test specificity of between 46% and 88%, estimating that for every 100 PIB scans in people with MCI, 28 people with a positive scan would not progress to Alzheimer’s dementia. 
This is not only a theoretical problem. Reliance on biomarker investigations without a keen awareness of the significant false positive rate risks iatrogenic harm through misdiagnoses; a possibility demonstrated by an included study in which CSF biomarkers did not improve clinicians’ prognostic accuracy but resulted in false positive predictions of future decline in patients with subjective complaints.186 
A small proportion of those with subjective cognitive symptoms progress to dementia; more likely where symptoms are new, progressive, where there is cognitive impairment (particularly of an amnestic nature), a degenerative brain disease biomarker profile, or a depressive pseudodementia picture.283 For some individuals with dementia it is possible, looking retrospectively, to identify a period of prodromal subjective symptoms, and (particularly in non-AD syndromes) this period may last several years before onset of dementia. Moreover, demonstrably functional cognitive symptoms may result from metacognitive impairment or psychiatric disorder occurring in prodromal Parkinson’s Disease, Lewy Body dementia, or frontotemporal dementia, just as functional motor symptoms have been reported in the prodrome of Parkinson’s Disease.284 This area of overlap and comorbidity will be an important area for future research.  However, overall, only a minority of subjective cognitive symptoms progress to dementia, and we suggest that this is in part because many of those with subjective cognitive symptoms have functional cognitive disorders (Figure 5). 
Clinically, functional cognitive disorders are, if not exactly under-recognised, considered not to be the primary business of the memory clinic. Functional cognitive disorders are infrequently discussed and rarely investigated in dementia research despite likely ubiquity in midlife and preclinical cohorts, and there is little evidence to guide diagnosis and treatment.  The harm associated with an incorrect clinical prediction of dementia cannot be underestimated. Importantly, though, identifying positive diagnostic profiles for functional cognitive disorders will improve accuracy of early degenerative brain disease diagnoses, so that only those most likely to be on a trajectory towards dementia are included in trials where aetiologically relevant levels of degenerative brain disease are a pre-requisite for target engagement and amelioration of the disease course. 
The diverse studies included identified in this review paint a picture of a broad functional cognitive disorder phenotype. Depressive symptoms are the commonest clinical association, in alignment with other reviews of subjective memory symptoms.285,286 Metacognitive error, present in most populations, was most marked in those with functional cognitive disorders, who significantly overestimated their deficits. Anxiety, neuroticism, negative self-beliefs, increased self-focused attention, and negative views of ageing are associated with more frequent and severe cognitive complaints. Distinctive patterns of behaviour and language during the clinical assessment (Table 8)3,287, and as also reviewed by Bailey et al.10) are strong candidate positive diagnostic signs for functional cognitive disorders.
Our findings are consistent with the aetiological framework proposed in Teodoro et al’s review of cognitive symptoms in functional neurological disorders, fibromyalgia, and chronic fatigue syndrome, which excluded ‘pure’ cognitive presentations: excessive self-attention and metacognitive error (supported by negative illness beliefs) lead to heightened experience of cognitive failure, effort, and illness (exacerbated by depressive symptoms, anxiety, and neuroticism), resulting inattention and cognitive failures maintaining the cycle.9
An inevitable limitation of this review results from difficulty in aligning results of studies using widely varying terminology and symptom assessment methods: our analyses of prevalence rates can be considered broadly indicative rather than precise. Our attempt to define and identify FCD from within the wider cognitive disorder is a necessary preliminary to future research. From here, prospective studies will be important to provide evidence for the utility of specific clinical features in making a positive (rather than by-exclusion) diagnosis, in order to define populations for much-needed trials of treatment, reduce iatrogenic harm, and improve accuracy of early degenerative brain disease diagnoses.

Figure 1 – selection of included studies




Figure 2 – Diagnoses in people attending memory clinics (30 studies, n = 11,807)
This chart shows the pooled distribution of diagnoses in the 30 included studies (n=11,807) of memory clinics (and similar services) which included adequate description of dementia and non-dementia diagnoses. Studies reporting ‘not dementia’ without alternative description are not represented here. 


Figure 3 – Subjective cognitive symptom prevalence vs mean sample age in 49 studies of community populations.








Table 1 – main terminology used in included studies
Number of included studies	Main term used
66	Subjective memory complaints
25	Pseudodementia
(13)	 - pseudodementia due to an affective disorder / depressive pseudodementia / pseudodementia of depression / dementia syndrome of depression
(1)	-  Conversion pseudodementia
23	Memory complaints
22	Subjective cognitive decline
15	Subjective memory impairment
14	Subjective cognitive impairment
12	Subjective cognitive complaints
10	Description of primary psychiatric diagnosis
10	Functional memory disorder
7	Clinically / cognitively normal / no cognitive deficits/disturbance
6	Cognitive complaints	
5	Not dementia / illness / (neuro)psychiatric illness / disease
5	Functional cognitive disorder
4	Subjective complaints
3	Memory self-report / self-rating / self-rated decline
3	Subjective memory loss
3	Subjective memory decline
2	Benign senescent forgetfulness
2	Worried well
1 each (15)	Cognitive symptoms, subjective cognitive symptoms, subjective memory symptoms, subjective forgetfulness, anticipatory dementia, memory problems, subjective cognition, subjective memory, subjective worsening of memory, symptoms of memory impairment, psychoactive brain dysfunction, Ganser syndrome, non-deteriorated (longitudinal), reversible dementia. 
Total: 251	


Table 2: Cross sectional studies of diagnosis following assessment for suspected cognitive disorder, ordered by year of publication (n=39) (italics = excluded from summary statistics)
Studies	Clinical Setting	Population	N	Mean age (range); % female	n (%) dementia  or another ‘organic’ cognitive disorder	n (%) MCI or equivalent	n (%) not dementia or another ‘organic’ cognitive disorder	n (%) subjective cognitive impairment +/- psychiatric disorder / pseudodementia*	n (%) specifically defined as functional cognitive disorders (FCD)	Descriptive terminology used to denote FCD, SCI (+/- psychiatric disorder), or pseudodementia diagnosis	Factors associated with FCD , SCI (+/- psychiatric disorder), or pseudodementia diagnosis
Marsden & Harrison 1972	Neurological hospital	patients admitted with a presumptive diagnosis of dementia	106	‘pre-senile'; not stated	83 (78)			10 (9.4)		8 (7.5%) depression, 1 hysteria, 1 mania	
Smith & Kiloh 1981	Neuropsychiatric institute	patients admitted with provisional diagnoses of dementia	200	57.7; 49%	90 (45)			20 (10)		pseudodementia (10 (5%) depressive illness, 7 (3.5%) schizophrenia, 2 (1%) hypomania, 1 (0.5%) depression and thyrotoxicosis)	Abrupt onset, short duration, depressive features, normal Ix. 
Rabins 1981	Psychiatric hospital	patients admitted with diagnosis of dementia or >60 with depression	57	not stated; not stated	37 (65)			13 (23)		cognitive impairment resolved with treatment of depression	
Reifler et al. 1982	Geriatric and Family Services Clinic	cognitively impaired geriatric outpatients	88	78; 71%				3 (3.4)		depression only accounting for cognitive symptoms	
Yerby et al. 1985	Geriatric and Family Services Clinic	patients presenting with complaints of memory loss	117	75.81; 72%	87 (74)			19 (16)		13% primarily depressed, 2.5% psychiatric or functional (postconcussion syndrome, paranoia, psychosis)	
Bayer et al. 1987	Memory clinic  	patients referred for assessment	100	74.2; 47%	67 (67)			12 (12)		9 depression, 3 'no significant problem'	
Van der Cammen et al. 1987	Memory clinic	patients referred for assessment	50	75.2; 64%	28 (56)			10 (20)		10% affective disorder, 10% no memory deficit and no diagnosis	
Erkinjuntti et al. 1987	Neurology outpatient clinic	patients evaluated because of suspected dementia	323	50.4; 55%	184 (57)			58 (18)		14% psychiatric disorder, 4.2% normal	Younger age
Derouesne et al. 1989	Memory clinic	subjects who attended a Memory clinic	367	62.9; 69%	26 (7)			62 (17)		‘psychoactive brain dysfunction'	
Brodaty et al. 1990	Memory disorders clinic	patients attending the Memory Disorders Clinic	144	69.5; 61%	106 (74)			27 (19)		12 (8.3%) psychiatric, 9 (6.3%) 'normal / anxious personality', 6 (4.2%) benign senescent forgetfulness (confirmed by no decline at 22 month follow-up)	Younger age
Weiner et al. 1991	Clinic for Alzheimer's and Related Diseases	individuals with subjective complaint or cognitive impairment 	317	not stated (all ages); not stated	295 (93)	6 (2)		11 (3.4)		2.5% depression, 1% somatization disorder	
Ames et al. 1992	Memory clinic	patients referred 	100	75.5; 75%	74 (74)			11 (11)		6% functional psychiatric disorder, 3 of 4 'other' ('marital problem', malingering, unspecified mental disorder'), 2 'nil' diagnosis	
Verhey et al. 1993	Multidisciplinary memory clinic	patients referred to and evaluated at the clinic	430	61.7; 44%	150 (35)			155 (36)		45 (10%) depression, 18 (4.2%) another psychiatric disorder	
Almeida et al. 1993	Memory clinic	patients assessed 	418	66.7; 57%	288 (69)			125 (30)		non-organic cause - 24% 'memory complainers, no diagnosis', 6% mood or neurotic disorders	Family history of dementia, unmarried, self-referred, younger, female
Wright and Lindesay 1995	20 memory clinics in the British Isles	Patients assessed during previous year	Not reported		Not reported (74.9)						
Swanwick et al. 1996	Specialist memory clinic	patients attending 	200	74.3; 71.5%	187 (94)	8 (4)	5 (6.5)				
Lehmann et al.1996	Memory center' (outpatient clinic)	patients who sought help at the memory center	406	62.9; 54%	48 (24)	142 (35)		154 (38)		‘no cognitive disturbance' (of whom 69 (17%) other psychotic symptoms, 46 (11.3%) depressive or neurotic symptoms, 7 (1.7%) neurasthenia, 3 personality disorder, 1 schizophrenia)	Self-referral, psychiatric disorders
Kopelman & Crawford 1996	Neuropsychiatry and memory disorders clinic	clinic attenders	200	43.7; 37%	26 (13) [114 (57) ‘organic cognitive impairment]			86 (43)		Include: 37 (18.5%) depression, 10.5% psychogenic amnesia, 9% PTSD, 1.5% 'worried well', 2 (1%) severe bereavement reaction	
Hogh et al. 1999	Multidisciplinary memory clinic	patients referred with symptoms & possible dementia	400	63.6; 48%	288 (72)			104 (26)		45 (11%) 'no psychiatric disease', 34 (8.5%) depression, 10 (2.5%) personality disorder, 5 (1.3%) schizophrenia, 3 0.7%) psychotic disorder, 2 (0.5%) anxiety disorder	
Luce et al. 2001	Memory clinic	patients referred	100	68.9; 56%	57 (57)			17 (17)		9% depression, 7% subjective memory impairment, 1% anxiety	
	Old age psychiatry catchment area service	patients referred	100	80.9; 65%	78 (78)			15 (15)		8% depression, 6 neurotic disorders, 1 schizophrenia	
Hejl et al. 2002	Multidisciplinary memory clinic	patients referred for diagnostic evaluation 	1000	66.1; 53%	580 (58)	170 (17)		240 (24)		14% 'no neuropsychiatric disease', 10% depression	
Elberling et al. 2002 - subset of population studied in Hejl 2002	Multidisciplinary memory clinic	patients referred age <60	314	47.6; 44%	15%					‘no cognitive deficits': of whom 29% no neuropsychiatric disease, 14.6% depression, 4.5% personality disorder, 1% each schizophrenia, anxiety disorder, PTSD, persistent mood disorder, 2.2% miscellaneous. Note: of those described as having neurologic disease 0.6% (2) had 'whiplash sequelae'	Family history of old-age dementia
Hejl et al. 2003	Memory clinic	patients referred for diagnostic evaluation  	100	74.2; 59%	55 (55)	11 (11)		20 (20)		24 (12%) affective disorder, 5 (2.5%) other psychiatric disorder, 10 (5%) no neuropsychiatric disorder	
Larner 2005	cognitive function clinic (neurology-led)	new referrals seen	247	not stated; not stated	121 (49)		126 (51)			Functional cognitive disorder	Attending alone
Banerjee et al. 2007	Memory service	referrals assessed by the Memory Service	247	not stated; 64%	156 (63)			74 (30)		‘no illness'	
Hancock and Larner 2009	Cognitive disorders clinic	Patients evaluated (2006-2008)	310	66.9; 49%	155 (50)						
Kenfield et al. 2010	Neurobehaviour clinic	patients seen at the clinic	342	(60.6 for the 109 with nonneurologic conditions - overall age not stated); 54% of ‘nonneurologic	218 (62)	21 (6) 		92 (27)		20% psychiatric disorder, 7% no neuropsychiatric disorder (not including 5% medical	Family history most common in nonneuropsychiatric group (56%), intermediate in psych (45.6%), lowest in medical (35%)
Wang et al. 2011	Memory clinic	patients who attended the clinic	2789	not stated (58% >70); 58%	1459 (52)	635(23)		695 (25)		21.7% subjective cognitive impairment, 3.3% neurosis	
Menon & Larner 2011	Cognitive disorders clinic	patients evaluated - 2004-2006	231	not stated; not stated	118 (51)		58 (49)				
		- 2008-2009	225	not stated; not stated	74 (33)		151 (67)				
		- 2009-2010	252	not stated; not stated	76 (30)		176 (70.0)				
Mascherek et al. 2011	Memory clinic	patients assessed at the clinic	169	76; 59%	66 (39)	40 (24)		63 (37)		Subjective cognitive complaints	Lower education and depressive affect 
Pennington et al. 2015	Cognitive clinic	patients on research database after cognitive clinic assessment	196	not stated; not stated					24 (12)	Functional cognitive disorder	
Claus et al. 2016	Memory clinic	patients with cognitive complaints	2000	78.2; 60%	1063 (53)	492 (25)		445 (22)		Subjective cognitive impairment	Higher education, younger age, white matter lesions. 
Sheng et al. 2018	Memory clinic	patients referred 	454	76.1; 60.4%	386 (85)	27 (6)		14 (3)		18 (4%) 'normal cognition', 15 (3.3%) psychiatric causes of reversible dementia (9 (2%) depression, 3 (0.7%) anxiety disorder, 2 (0.4%) psychosis, 1 (2.2%) adjustment disorder)	
Verity et al. 2018	Memory clinic	patients seen	375	70.76; 57%	247 (78)			83 (22)		Worried well	Higher education, previous psychiatric diagnosis, higher alcohol intake, sleep problems.
Elhadd et al. 2018 and Bharambe & Larner 2018	Cognitive disorders clinic	new outpatients	89	median 62 (22-88); 48%	9 (10) dementia	26 (29)			51 (57)	Functional cognitive disorder	Disturbed sleep on dichotomised Jenkins Sleep Scale (83% vs 50%); SMC likert (poor or fair), attending alone, ‘la maladie du petit papier’, family history. 
Randall et al. 2018	Cognitive disorders clinic	new outpatients 	169	median 60; 47.6%	69 (41) ‘cognitive disorders’		100 (59)			No cognitive impairment	
Bharambe & Larner 2018	Cognitive disorders clinic	new outpatients	169	60; 53%	30 (18)	41 (24)			95 (56)	Functional cognitive disorder	
Larner 2018	Cognitive disorders clinic	new outpatients 	50	60.5 median (26-84); 52%	4 (8) 	20 (40)		26 (52)		Subjective memory complaints	
Total:39 studies			13637	69 ( of N=8628); 57% female (of N=11664)	7173 (54% of N=13353), including other ‘organic’ cognitive disorders	1686 (20% of N=8460)	616 (47% of N=1324)	2662 (22% of N=11549)	170 (37% of N=11549)		
* a proportion of cases defined as such may be alternatively described as having functional cognitive disorders  (FCD)
				



Table 3 – Studies reporting prevalence of cognitive symptoms in non-clinical populations (n=38) (bold = also report longitudinal data)
Name	Population	N	Mean age (range); % female	%  symptoms	Terminology	Symptom prevalence assessment method; other measures of cognitive symptoms
Grut et al. 1993	all inhabitants of an area in Sweden	614	(>75); not reported	30%	memory complaints	Single item from Comprehensive Psychopathological Rating Scale (CPRS) (Perris et al 1984): ‘1. No memory complaints, 2. Occasional memory disturbances, 3. Disturbance embarrassing or almost total memory loss’
Spear-Bassett et al. 1993	Eastern Baltimore Mental Health Survey	810	(18-92); 65%	22%	memory complaint	Single question: ‘Do you find that you have trouble with your memory?’
Jorm et al. 1994	electoral roll sample of elderly people	744	(>70); 49%	62%	memory complaints	Single question (part of study-specific questionnaire): ‘Overall, do you feel you can remember things as well as you used to? That is, is your memory the same as it was earlier in life?’
Tobiansky 1995	Gospel Oak Study (electoral ward sample)	705	74.6; 63%	25%	subjective memory impairment	≥3 on short-CARE SMI scale
Collins et al. 1996	recruited through advertisement to Michigan State University Psychological Clinic Aging Research Project 	90	70.4; 74%	42%	subjective memory complaints	MAC-S score ≤19 
Smith et al. 1996	population-based older americans normative study	394	72.1; 56%	78%	subjective memory complaints	Single item from MFQ (Gilewski et al. 1990): ‘How would you rate your memory in terms of the kinds of problems you have?’
Blazer et al. 1997 	Duke Established Populations for Epidemiologic Studies of the Elderly	3080	72; 67%	56%	memory complaint	Single question: ‘Is your memory getting worse?’
Braekhus et al. 1998	Norwegian population cohort ≥ 75	285	81.5; 78%	37%	subjective worsening of memory	Single question ‘Is it more difficult to remember things than it used to be?’
St John et al. 2002	Manitoba Study of Health and Aging	1416	75.3; 60%	21%	subjective memory loss	Single question: 'Please tell me if you have had memory loss in the past year.'
Jungwirth et al. 2004	75 year-olds from population register	302	75; 63%	11%	subjective memory complaints	Single question: ‘Do you have complaints about your memory in the last 2.5 years?’
Wolf et al. 2005	research clinic volunteers	46	61.8; 54%	59%	subjective memory complaints	2 on Global Deterioration Scale: ‘Subjective complaints of memory deficit, most frequently in following areas: (a) forgetting where one has placed familiar objects; (b) forgetting names one formerly knew well’; MAC-Q
Lautenschlager et al. 2005	community-dwelling women >70 recruited via advertisement	264	74.5; 100%	60%	subjective memory complaints	Single question: ‘Do you have any difficulty with your memory?’
Glodzig-Sobanska et al. 2007	volunteers (‘normal subjects’ to a study of aging	230	67; 66%	81%	subjective memory complaints	GDS = 2: ‘awareness and complaint of memory change in comparison with prior adult capacity, in the absence of objective evidence of memory or functional problems’
Park et al. 2007	Ajou-Bundang Study for the Elderly cohort	9477	72.6; 61%	57%	subjective memory complaints	'Do you think you are suffering from memory impairment in comparison to a year ago?'
Van Oijen 2007	Rotterdam Study (population-based cohort)	6927	69.5; 60%	19%	subjective memory complaints	Single question: ‘Do you have memory complaints?’
Brucki and Nitrini 2009	Adults with low education, rural amazon rainforest	163	62.3; 50%	70%	subjective memory impairment	Single question: ‘Do you have memory problems?’
Westoby et al. 2009	Population from 3 GP practice registers	7878	66.3; 56%	47%	cognitive complaint 	>0 on Alertness Behaviour Subscale of Sickness Inventory Profile
Gino et al. 2010	volunteers attending health screening unit, blood donors, leisure centre, senior citizens college or university in Lisbon	946	54.2; 60%	76%	Subjective memory complaints	Item 1 of SMC scale: ‘Do you have any complaints concerning your memory?’; SMC Scale (Schmand et al 1996)
Slavin et al. 2010	electoral roll	827	63; 68%	65%	subjective cognitive complaints	Single question: ‘Have you noticed difficulties with your memory?’; MAC-Q
Amariglio et al. 2011	women participating in the Nurses' Health Study	16964	74; 100%	56%	subjective memory complaints	Study-specific questionnaire
Aarts et al. 2011	population postal survey	15188	70; 33%	2%	Subjective memory complaints	‘Do you consider yourself forgetful?’ AND ‘Have your memory complaints increased in the past year?’
Cooper et al. 2011	Adult Psychiatric Morbidity Survey	7461	45; 57%	32%	subjective forgetfulness	Single question: ‘Have you noticed problems with forgetting in the last month?’; MFQ
Paradise et al. 2011	45 and Up Study (Australia cohort) between 45 and 64 years	45532	(>45); 55%	12%	subjective memory complaints	Subjective Memory Complaints (SMC) Likert: 'In general, how would you rate your memory?' 1 poor, fair, good, very good, 5 excellent
Bartley et al. 2012	healthy subjects recruited through public awareness meetings in retirement clubs and from relatives of impaired subjects	96	61.8; 73%	54%	subjective memory complaints	Single question and  4 questions from SMC scale (Schmand et al 1996)
Caracciolo et al. 2012	population based sample of twins	11926	(≥65); 55%	39%	subjective cognitive impairment	Single question: ‘Have you noticed any change in your memory during the last three years?’
Balash et al. 2013	volunteer or self-referral	636	68; 61%	80%	subjective memory complaints	Single question: Do you feel like your memory or thinking is becoming worse? (1=no, 2=yes but not worried, 3=yes and worried)
Genziani et al. 2013	Population survey (French community surveys)	9294	74.3; 21%	21%	subjective memory impairment	3C study-specific questionnaire
Ito et al. 2013	Population survey	2034	74.6; 60%	46%	subjective memory complaints	‘Do you feel that your memory has worsened in the last 6 months?’
Rijs et al. 2013	Longitudinal Aging Study Amsterdam	910	60.2; 52%	21%	memory complaints	‘Do you have complaints about your memory?’
Siersma et al. 2013	People attending GP (any reason)	758	74.8; 61%	23%	subjective memory complaints	‘less good’, ‘poor’, or ‘miserable’ for ‘How would you judge your memory?’
Acikgoz et al. 2014	Patients attending neurology, cardiology, and physical therapy clinics but NOT for cognitive complaints	405	64.5; 63%	43%	subjective memory complaints	Single question: ‘Do you have forgetfulness which affects your daily life?’; SMC scale
Begum et al. 2014	Population sample (English Psychiatric Morbidity surveys 1993, 2000, 2007)	26091	42; 51%	9.6%	subjective memory complaints	Single question: ‘Have you noticed any problems with forgetting things in past month?’ + problem noticed  ≥ 1 day / past week
Caselli et al. 2014	healthy members of Arizona Apolipoprotein E cohort 	447	59; 69%	31%	subjective cognitive decline	Score >0 on Multidimensional Assessment of Neurodegenerative Symptoms questionnaire (MANS)
Chen et al. 2014	telephone survey of representative community population	4423	(18-39); not reported	14%	subjective memory impairment	‘a single question about the presence of perceived memory problems'
		6365	(40-59); not reported	22%		
		6365	(60-99); not reported	26%		
Mewton et al. 2014	NSMHWB sample - population survey	1905	(65-85); not reported	34%	subjective memory complaints	Study-specific questionnaire: ‘Compared with others your age, how would you rate your memory?' and 'Compared with 5 years ago, how would you rate your memory?'
Singh-Manoux et al. 2014	French GAZEL study	15510	57.9; 26%	56%	subjective cognitive complaints	Single question (part of study-specific questionnaire): ‘Have you experienced memory problems?’
Tomita et al. 2014	volunteers >60 participating in 'Iwaki Health Promotion Project' (2011)	394	68.7; 65%	24%	subjective memory complaints	Single question: ‘Have you been distressed by your forgetfulness?'
Kaup et al. 2015	community-dwelling older women in a study of ageing	1107	70.8; 100%	8%	subjective memory complaints	Single question: ‘Do you feel you have more problems with memory than most?’
Montejo et al. 2011 (also described in Montejo et al 2012, and Montejo et al 2016)	Madrid Health Survey	1637	74.7; 60%	32%	subjective memory complaints	Single question: ‘Do you have memory problems?’
Roehr et al 2016	Leipzig longitudinal study of the aged (LEILA75+)	453	80.5; 73%	31%	subjective cognitive decline	'assumed if unimpaired and stated to have memory problems unrelated to an event or condition explaining the memory problems according to recent research criteria.'
Tanaka et al. 2016	twins age ≥ 20 years	556	51; 70%	72%	subjective memory complaints	Single question: ‘Do you consider yourself as being forgetful?' during past week (0 not at all to 4 extremely)
Wolfsgruber et al. 2016(smaller subset of this cohort also described in Jessen et al. 2007)	cognitively normal participants AgeCoDe study	1990	80.1; 66%	32%	subjective memory complaints	Single question: ‘Do you feel like your memory is becoming worse?’
Kuiper et al. 2017	older adults in LifeLine cohort study	8762	70; 52%	55%	subjective memory complaints	Single question: 'Do you have complaints about your memory?'
Markova et al. 2017	cognitively healthy volunteers	340	75; 55%	71%	subjective cognitive complaints	≥ 1/10 complaints on QPC questionnaire
Sakurai et al. 2017	'local resident registration' - >65, no cognitive impairment (MMSE>24) 	496	72.7; 57%	45%	subjective memory complaints	Single question: 'Do you have problems with your memory?'
Yates et al. 2017	older people in MRC-CFAS population-based study	1344	74; 64%	41%	subjective memory complaints	‘Yes’ to any of: 'Have you ever had difficulty with your memory', 'Have you tended to forget things recently?' and 'Have you had any difficulty with your memory'
Avila-Villanueva et al. 2018	Vallecas Project cohort	1091	74.7; 64%	78%	Subjective cognitive decline	Study-specific questionnaire
Cosentino and Devanand 2018	Participants in North Manhattan Aging Project (NMAP)	471	72.8; 67%	58%	subjective memory complaints	Endorses least one symptom 10-item subjective memory complaint scale from Comprehensive Assessment and Referral Interview (CARE)
Nunes et al. 2018	 Brazil final year medical students	59	25.7; 46%	71%	self-perceived memory difficulties, memory complaints	SMC scale score  ≥3 (Schmand et al 1996)
Flatt et al. 2018	older (>50) LGBT adults from LGBR community centre	210	59.6; 24%	25%	subjective cognitive decline	Memory problems AND problems in one other cognitive domain; as part of Medical Outcomes Study (MOS) HIV health survey 
Hall et al. 2018	cognitively normal Mexican-American elderly people in a cohort study (HABLE) 	319	58.91; 80%	42%	cognitive complaints	Single question: ‘each participant was asked if they were concerned about changes in memory and thinking. Those responding in the positive were classified as having subjective cognitive complaints.’
Sanchez-Benzvides et al. 2018	cohort of cognitively healthy middle-aged first-degree descendents of AD patients (47.4% onset <75)	2670	55.8; 63%	21%	subjective cognitive decline-plus	Single question: 'Do you perceive memory or cognitive difficulties?'; SCD-Q
Schweizer et al. 2018	Cam-CAN cohort of adults free of neuropsychiatric disorders	2544	59.5; 56%	38%	subjective memory complaints	Single question: ‘Do you feel you have problems with your memory?’
Luck et al. 2018	40-79 general population - LIFE adult cohort	8834	58.8; 52%	53%	subjective cognitive symptoms	Single question (part of study-specific questionnaire): ‘Do you feel as if your memory is becoming worse?'
Meyer et al. 2018		stratified sample adults ≥ 55	600	70.3; 50%	39%	subjective memory complaints	Study-specific questionnaire: memory poor AND interferes with life
Brailean 2019	English Longitudinal Study of Ageing	11092	65.3	57%	subjective memory complaints	‘poor’ or ‘fair’ on SMC Likert
Total:		245654		30%		
																	



Table 4 - Neuropsychological test performance in comparison with controls
Observation / Study name	Description of participants (cases)	Measure
No impairment compared with asymptomatic healthy controls 
Benito Leon et al. 2010	subjective memory complaints (community sample)	MMSE et al. 
Wakefield et al. 2018	functional memory disorder	MMSE et al. 
Jenkins et al. 2019	healthy volunteers with and without SCI	Similar multi-item localization (MILO) task performance
Smart et al. 2015	subjective cognitive decline (community sample)	Iowa gambling task 
Impaired compared with asymptomatic healthy controls
Archer et al. 2006	MCI and SNCI (symptoms no cognitive impairment)	SCNI impaired on immediate and delayed recall (MMSE) and TRAILSB 
Gainotti et al. 2008	depressive pseudodementia	Rey’s Auditory Verbal Learning Test 
Benito Leon et al. 2010	subjective memory complaints (community sample)	Verbal fluency and recall (MMSE) 
Puetz et al. 2011	functional memory disorder	Similar declarative memory consolidation before but impaired after a night of sleep 
Svendsen et al. 2012	patients with affective disorders	Impaired on cognitive screening tests
De Paula et al. 2013	patients with depressive pseudodementia	Impaired immediate and delayed recall but preserved recognition memory (RAVLT)
Lehrner et al. 2014	patients with cognitive complaints	Impaired compared with controls
Hu et al. 2017	subjective cognitive decline (clinical sample)	increased delay-discounting on an intertemporal decision-making task
Jenkins et al. 2019	healthy volunteers with and without SCI	Some with SCI had disproportional slowing and greater intra-individual reaction time variability
Similar performance to non-help-seekers with SMC
Ramakers et al. 2009	subjective memory complaints (clinical sample)	Similar MMSE performance to non-help-seekers
Less impaired than MCI controls 
Archer et al. 2006	MCI and SNCI (symptoms no cognitive impairment)	MMSE et al. 
Wakefield et al. 2018	functional memory disorder	MMSE et al. 
Less impaired than dementia controls
Gainotti et al. 2008	depressive pseudodementia	RAVLT
Sahin et al. 2017	depressive pseudodementia	Wechsler Memory Scale (WMS) subtests et al.
Wallert et al. 2018	subjective cognitive impairment (clinical sample)	Simple reaction time faster than in dementia or MCI

Table 5 - Relationship between cognitive symptoms and measured performance
Study	Cognitive symptoms associated with objective cognitive impairment?	Setting	Participants	
Larrabee and Levin 1986	Yes	community	volunteers	self-rated remote memory associated with objective measures of recent and remote memory. 
Sunderland et al. 1986	Yes	community	healthy adults	subjective memory correlated weakly with test performance. 
McGlone et al. 1990	No	clinical	patients with and without dementia; HC	symptom scores did not differ between patients with and without dementia. 
Rabbitt and Abson 1990	No	community	volunteers	
Bolla et al. 1991	No	community	volunteers	
Christensen et al. 1991	Yes	community	volunteers with 'memory problems'; dementia; HC	objective performance and complaint associated in subgroup; no relationship between specific everyday failures and objective performance 
Crook and Larrabee 1992	Yes	clinical	AAMI	self-rated memory correlated with memory test scores 
Lucas et al. 2003	Yes	clinical	medically unexplained cognitive difficulties	50% had objective cognitive impairment, which was associated with depressed mood.
Jungwirth et al. 2004	No	community	75 year olds 	
Zandi 2004	Yes	clinical	memory clinic patients	
Minett et al.2005	No	clinical	memory clinic patients	subjective memory complaints no longer correlated with cognitive performance when white matter lesion severity and depressive symptoms were controlled for
Pearman et al. 2005	No	community	volunteers 	
Jessen et al. 2007	No	community	volunteers without dementia or MCI 	SMI were only associated with impaired delayed recall in a non-depressed subset
Gallassi et al. 2008	Yes	clinical	memory clinic patients with SCC	49/92 had objective deficits
Mendes et al. 2008	No	community	healthy volunteers	
Svendsen et al. 2012	No	clinical	outpatients with bipolar and unipolar depression; HC	
Buckley et al.2013	No	community	elderly volunteers	
Rijs et al. 2013	Yes	community	aging study cohort participants 55-64	SMC associated with poorer delayed recall and decline in learning ability
Steinberg et al. 2013	Yes	community	volunteers ≥ 65 without cognitive impairment	SMC associated with poorer executive function and delayed recall
Lehrner et al. 2014	Yes	clinical	patients with cognitive complaints; HC	
Chin et al. 2014	No	clinical	memory complaints but normal cognitive testing	
Tomita et al. 2014	Only in men	community	healthy volunteers	SMC associated with objective impairment on MMSE only in men, not women
Zlatar et al. 2014	Yes	community	participants in study of ageing	weak association between cognitive symptoms and cognitive function; moderate association between cognitive symptoms and depressive symptoms
Chu et al. 2017	Yes	clinical	>60 + history of depression; HC	SMC associated with worse recall only in those with depression history. 
Kang et al. 2017	No	community	Population-based cohort	
Schweizer et al. 2018	No	community	Healthy volunteers	
Schwert et al. 2018	No	clinical	depressed outpatients; HC	Cognitive complaints exceeded measured deficits in depressed outpatients. HC overestimated own cognitive function
Slot et al. 2018	Yes	clinical	memory clinic patients with SCD; HC	
Kawagoe et al. 2019	No	clinical	individuals with SMC	



Table 6 - Interactional, linguistic, behavioural variables
Study	n cases (controls)	Description of participants 	Comparitors	Measure	Relationship
Linguistic / conversation analysis of clinical assessment
Wells 1979	10	pseudodementia 		clinical assessment	pseudodementia: detailed description of complaints, 'don't know' answers, complain of memory loss 'with vigour and feelings'
Elsey et al. 2015	15 (15)	functional memory disorder	neurodegenerative disease 	conversation analysis 	those with functional memory disorder interacted more confidently, provided extended and detailed accounts of difficulties
Jones et al. 2016	16 (9)	functional memory disorder	neurodegenerative disease	conversation analysis	functional memory disorder: more detailed account of memory failures, able to answer personal questions, display working memory in interaction, respond to compound questions, more time taken to respond
Mirheidari et al. 2017	15 (15)	functional memory disorder	neurodegenerative disease	conversation analysis with machine learning techniques (manual transcripts)	automated analysis using Elsey et al. 2015 features, number of unique words & 'accompanying person' turns correctly classified 93-97% 
Alexander et al. 2018	17	functional memory disorder		communication features	functional memory disorder: draw attention to how symptoms differ from normal, report 3rd-party observations and 3rd-party speech
Lundholm Fors et al. 2018	54 (36)	subjective cognitive impairment and MCI	healthy controls	syntactic analysis of 'Cookie-Theft' transcriptions 	no difference in syntactic complexity between groups
Reuber et al. 2018	20 (20)	functional memory disorder	neurodegenerative disease	conversation analysis	linguistic and interactional features predict diagnoses of neurodegenerative disease or functional memory disorder 
Attending alone
Larner 2005	247	cognitive clinic attenders		attending alone despite written instruction to bring relative, friend, or carer	‘attending with’ 100% sensitive and 35% specific for dementia
Larner 2014	726	cognitive clinic attenders		attending alone despite instruction to bring a relative, friend, or carer	attending alone was 100% sensitive and 40% specific for absence of dementia
Elsey et al. 2015	15 (15)	functional memory disorder	neurodegenerative disease	conversation analysis of transcripted consultations	functional memory disorder: more likely to attend alone, rarely sought assistance from companion. 
Soysal et al. 2017	529	memory clinic attenders	cognitive impairment 	'attended with' accompanying adult	‘attended with’: 90% sensitive and 37% specific for cognitive impairment
Kambe et al. 2018	21 (75)	unaccompanied older adults with memory complaints	accompanied	MRI	unaccompanied had more depressive symptoms
Behaviours observed during clinical assessment
Soysal et al. 2017	529	memory clinic attenders	 	head-turning to a relative seated behind patient and at 45 degrees during questions about complaints	Head turning 80% sensitive and 64% specific for cognitive impairment; attended with 90% sensitive and 37% specific for cognitive impairment
Randall et al. 2018	169	cognitive disorders clinic attenders		La maladie du petit papier (presentation of written or typed symptom list patient at consultation)	producing a written list of complaints: high specificity (0.94) but low sensitivity (0.03) for diagnosis of functional cognitive disorder

Table 7 - Depressive symptoms, anxiety symptoms, and personality factors in individuals with subjective / functional cognitive symptoms
Variable / study name	Source	Description of participants (cases)	Measure	Associated withsymptoms / symptom severity? 
Depressive symptoms (studies of depressive pseudodementia excluded)				
Kiloh 1961	clinical	Pseudodementia 	clinical assessment	Yes
Kahn et al. 1975	clinical	psychiatry inpatients and outpatients; HC	Do you have any trouble with your memory?' rated/5, HDRS	Yes
Wells 1979	clinical	Pseudodementia	clinical assessment	Yes
Caine 1981	clinical	Pseudodementia 	clinical assessment, including neuropsychological assessment	Yes
Bulbena and Berrios 1986	clinical	pseudodementia	clinical assessment	Yes
Larrabee and Levin 1986	community	volunteers	Squire et al. (1979) memory rating scale; ZDRS; memory tests	Yes
Minett et al. 2005	clinical	memory clinic patients	MAC-Q, GDS	Yes
Crook and Larrabee 1990	community	volunteers	MAC-S, GDS	Yes
O'Connor et al. 1990	community	sample of adults >75 from GP registers	CAMDEX, clinical assessment	Yes
Rabbitt and Abson 1990	community	volunteers	CFQ, MFQ, 'Lost and Found' questionnaire, BDI	Some questionnaires only
Bolla et al. 1991	community	volunteers	MMQ, GDS, memory tests	Yes
Crook and Larrabee 1992	clinical	Age-Associated Memory Impairment (AAMI)	MAC-S, HDRS, elements of WMS + others	No
Barker et al. 1994	clinical	individuals with memory symptoms; HC	MAC-Q, GDS	Yes
Barker and Prior 1995 	clinical	self-referral memory clinic attenders; HC	MAC-Q, GDS	Yes
Levy-Cushraan and Abeles 1998	community	older adults	MAC-S, BDI, GDS	Yes
Derouesne et al. 1999	clinical	self-referrers to memory clinic; HC	SMS scale, Zung depression scales	Yes
Clarnette et al. 2001	community	volunteers	‘volunteers with memory complaints’, CAMDEX	Yes
Small et al. 2001	community	volunteers with mild age-related memory complaints	MFQ, HAM-D, APOE4 status	Only in those without APOE4 allele
Lucas et al. 2003	clinical	medically unexplained cognitive difficulties	BDI, elements of WMS	-
Jungwirth et al. 2004	community	75 year olds	HAMD, GDS	Yes
Zandi 2004	clinical	memory clinic patients	CAMDEX, CAMCOG	Yes
Jessen et al. 2007	community	sample of adults from GP registers	SIDAM, elements of CERAD, GDS	Yes
Sinforiani et al. 2007	clinical	memory symptoms not impairing activities	BDI, STAI X-1, STAI X-2	Yes
Gallassi et al. 2008	clinical	outpatients with cognitive complaints	BDI	SCI less depressed than MCI
Mendes et al. 2008	community	healthy volunteers	SMC scale, CERAD depression scale / GDS	Yes
Metternich et al. 2009	clinical	FMD, HC	MIA, BDI	Yes
Ramakers et al. 2009	clinical	SMC	MIA, SCL-90	-
Schmidtke et al. 2009	clinical	FMD, HC	SCID (DSM-IV) Axis 1 and BDI	Yes
Benito Leon et al. 2010	community	SMC (including some with MCI); HC	Do you suffer from forgetfulness since the last interview?'; 'Do you suffer from depression?’; antidepressant use	Yes
Svendsen et al. 2012	clinical	affective disorders; HC	MGH Cognitive and Physical Fx Questionnaire and Screen for Cognitive Impairment in Psychiatry, HDRS	Yes
Sindi et al. 2012	community	older adults (58-85)	study-specific aging perceptions questionnaire; EMQ (Everyday memory questionnaire), GDS	Yes
Genziani et al. 2013	community	older adults >65	CES-D, study-specific questionnaires 	Yes
Merema et al. 2013	community	older adult volunteers	General Frequency of Forgetting scale, Depression Anxiety Stress Scale, Neo Five Factor	Not when neuroticism included
Buckley et al. 2013	community	elderly volunteers	MAC-Q, GDS, HADS	Yes
Apolinario et al. 2013	clinical	older adults with subjective cognitive symptoms	Novel classification system (type of complaints); Memory Complaint Questionnaire (MAC-Q); GDS-15	Yes
Chin et al. 2014	clinical	memory complaints & normal testing	MMQ, GDS short form (S-GDS)	Yes
Lehrner et al. 2014	clinical	patients with cognitive complaints; HC	Forgetfulness Assessment Inventory (FAI), BDI	Yes
Zlatar et al. 2014	community	participants in study of aging	CFQ, PHQ-9	Yes
Arbabi et al. 2015	clinical	memory clinic patients with SMC	WMS, HADS	-
Eckerstrom et al. 2016*	clinical	SCI	clinical interview	No 
Kinzer and Suhr 2016	community	volunteers	Dementia worry scale, GDS, Penn State Worry Questionnaire	Yes
Rowell et al. 2016	community	healthy adults 	MFQ, MAC-S, CES-D	Yes
Tanaka et al. 2016	community	MZ and DZ twins from research register	Depression-dejection scale from POMS-brief; study-specific question	Yes
Vogel et al. 2016	clinical	patients with mild cognitive symptoms	SMC scale and MAC-Q scale, MDI	Yes
Markova et al. 2017	community	cognitively healthy volunteers	QPC, GDS	Yes
Perrotin et al. 2017	clinical	patients with SCD; non-help-seeking SCD	cognitive difficulties scale, MADRAS	More depressive symptoms in help-seekers
Kambe et al. 2018	clinical	unaccompanied memory clinic attenders; accompanied attenders	MRI, MMSE, CES-D	More depressive symptoms in unaccompanied patients
Schweizer et al. 2018	community	Cam-CAN cohort – adults free of neuropsychiatric disorder	HADS, WMS	Yesa
Slot et al. 2018	clinical	memory clinic patients with SCD; HC	Cognitive Change Index, HADS-D	Yes
Zlatar et al. 2018	clinical	older adults referred for screening of cognitive complaints	study-specific 5-item SCD scale, GDS	Yes
Jenkins et al. 2019	community	healthy volunteers	Cognitive Change Index (CCI), HADS	Yes
Kawagoe et al. 2019	clinical	individuals with SMC	SMS questionnaire (Osada 1997), Zung SDS	Yes
Anxiety				
Reynolds et al. 1988	clinical	Depressive pseudodementia; dementia with depressive features	HRSD	Yes 
Barker and Prior 1995 	clinical	individuals attending a self-referral memory clinic; HC	STAI-T	Yes – trait anxiety
Derouesne et al. 1999	clinical	self-referrers to memory clinic; HC	SMS questionnaire Zung anxiety scale	Yes
Clarnette et al. 2001	community	volunteers	‘volunteers with memory complaints’, CAMDEX	Yes
Jungwirth et al. 2004	community	75 year olds	HAMD, STAI	Yes
Sinforiani et al. 2007	clinical	memory symptoms not impairing activities	STAI X-1, STAI X-2	Yes
Ramakers et al. 2009	clinical	SMC; non-help-seeking SMC	MIA, SCL-90	Similar anxiety in help-seekers and non-help-seekers
Hurt et al. 2011	clinical	adults with SMC attending memory clinic; non-help-seeking SMC	Illness Perception Questionnaire for Memory Problems (IPQ-M), Beck Anxiety Inventory	Yes – anxiety determined by negative beliefs about symptoms
Buckley et al. 2013	community	elderly volunteers	MAC-Q, HADS	Yes
Arbabi et al. 2015	clinical	SMC with and without impairment	HADS, WMS, MMPI	Yes
Rowell et al. 2016	community	healthy adults 	MFQ, MAC-S, STAI-T	Yes
Tandetnik et al. 2017	community	volunteers without cognitive impairment	trait-STAI-Y, HADS-A	Yes – trait anxiety
Slot et al. 2018	clinical	memory clinic patients with SCD; HC	Cognitive Change Index, HADS-A	Yes
Jenkins et al. 2019	community	healthy volunteers	Cognitive Change Index (CCI), HADS	Yes
Personality factors				
Hanninen et al. 1994	community	memory complainers; noncomplainers	MMPI	Yes – hypochondriasis and psychaesthenia scales
Hepple et al. 2004	clinical	conversion pseudodementia	clinical assessment	‘predisposing personality traits’
Pearman et al. 2005	community	SMC	NEO PI-R, self-esteem scale	self-discipline and self-consciousness
Ramakers et al. 2009	clinical	SMC; non-help-seeking SMC	Eysenck Personality Questionnaire (EPQ-BV)	similar extraversion and neuroticism in help seekers and non-help-seekers
Schmitdke et al. 2009	clinical	FMD outpatients; HC	NEO-Five Factor Inventory	Yes - neuroticism
Metternich et al. 2009	clinical	FMD; HC	NEO-Five Factor Inventory	Yes - neuroticism
Merema et al. 2013	community	older adult volunteers	General Frequency of Forgetting scale, Neo Five Factor	Yes - neuroticism
Steinberg et al. 2013	community	volunteers ≥ 65 without cognitive impairment	Prospective Retrospective Memory Questionnaire (PRMQ), Neo Five Factor Inventory	Yes - neuroticism
Studer et al. 2014	clinical	MCI; HC	QPC (French cognitive complaint quesitonnaire), NEO-PI-R	Negative association between SCD (in MCI) and agreeableness
Arbabi et al. 2015	clinical	SMC with and without impairment	MMPI	Yes – hysteria
Rowell et al. 2016	community	healthy adults 	MFQ, MAC-S, Emotional Stability subscale from IPIP questionnaire	Yes – emotional instability
Tandetnik et al. 2017	community	volunteers without cognitive impairment	McNair and Kahn self-rated cognitive questionnaire, Young's Early Maladaptive schemas (YSQ-short form)	Yes – maladaptive schemas ('dependence/incompetence', 'failure to achieve', and 'vulnerability to harm or illness')
Bessi et al. 2018	clinical	SCD or MCI	Big Five Factors Questionnaire	Lower emotional stability in stable SCD compared with progressive SCD
Jenkins et al. 2019	community	healthy volunteers	Cognitive Change Index, Big Five Inventory  	Yes – neuroticism
Slot et al. 2018	clinical	memory clinic patients with SCD; HC	Cognitive Change Index - Self, and subjective cognitive function self-report (compared 1 year ago) , NPV neuroticism subscale, Pearline Mastery scale	Yes – neuroticism and low mastery

Table 8 – Clinical observations in functional cognitive disorders vs. degenerative brain disease (adapted from (Griem et al., 2016; Stone et al., 2015)). 

(caption) The following clinical features often observed in functional cognitive disorder (left hand column) are candidate positive signs of functional cognitive disorder which merit prospective examination in mixed clinical cohorts. 

Clinical signs
Functional cognitive disorders	Degenerative brain disease
Attends alone	Attends with someone
Patient more aware of the problem than others	Others more aware of the problem than patient
Answers independently	Turns to accompanying adult for support in answering questions (head turn sign)
Gives a detailed description of complaints (may bring written list) 	Account of symptoms lacking in detail
Frequently offers elaboration and detail	Unlikely to give spontaneous elaboration or detail
Can answer questions with multiple components	Can only answer single-component questions
Detailed account of personal history, drugs, previous interactions with doctors	Less detailed account
Loss of recent and remote autobiographical memories	Relative preservation of remote autobiographical memories
Complaint of memory ‘gaps’ for specific periods and events	Complaint of specific memory ‘gaps’ unusual
Memory symptoms may be within most people’s normal experience	Memory symptoms are often outwith normal experience
Approximate answers / vorbeigehen (answers which indicate that the correct answer is known at some level)	No approximate answers / vorbeigehen
Dates symptom onset with precision	Difficult to pinpoint date of onset
Unstable longitudinal course	Cognitive impairment progressive over time
Marked variability	Less variability
Supplementary table A – all included studies, ordered by date of publication  (*,**, *5 etc = studies of same or overlapping population)
Author and year	Design	Source	Terminology	n  	Population	Controls	Age, mean / [median]
Kiloh 1961	case series	clinical	pseudo-dementia	10	patients with pseudodementia		51.4
Marsden and Harrison 1972	cross sectional	clinical	primary psychiatric diagnoses	106	neurology inpatients diagnosed with presenile dementia		not stated
Tsoi 1973	case series	clinical	other - Ganser syndrome	10	patients diagnosed with Ganser syndrome in Singapore		35.4
Kendell 1974	longitudinal	clinical	primary psychiatric diagnoses	98	psychiatry inpatients with dementia diagnosis, readmitted at least once		not stated for subgroup
Kahn et al. 1975	cross sectional	clinical	cognitive complaints	82	gerontology psychiatry outpatients and inpatients	 40 HC	65.1
Nott and Fleminger 1975	longitudinal	clinical	other - 'non deteriorated group'	35	inpatients diagnosed with presenile dementia		53.2
Wells 1979	case series	clinical	pseudodementia	10	psychiatry and neurology patients with pseudodementia		not stated
Caine 1981	case series	clinical	pseudodementia	11	inpatients with a descriptive label of pseudodementia		49.9
Rabins 1981	cross sectional	clinical	other - reversible dementia	41	patients with dementia and elderly patients with depression admitted to a psychiatric hospital		not stated
Smith and Kiloh 1981*	cross sectional	clinical	pseudodementing illness	200	patients admitted to neuropsychiatry with presumed dementia		57.7
Reifler et al. 1982	cross sectional	clinical	cognitive symptoms	88	cognitively impaired geriatric outpatients		78
Hutton et al. 1984	cross sectional	clinical	pseudodementia of depression	17	outpatients with 'pseudodementia of depression'	19 presumed AD, 17 HC	69.1 (69.2 (73 AD, 65 DPD); 69 controls)
Yerby et al. 1985	cross sectional	clinical	depression, psychiatric or functional disorders	117	geriatric clinic outpatients with complaints of memory loss		75.81
Bulbena and Berrios 1986	longitudinal 	clinical	pseudodementia	22	inpatients with diagnosis of pseudodementia		73.3
Sunderland et al. 1986 	cross sectional	community	memory complaints	60	residents of housing for elderly adults 		68.6
Larrabee and Levin 1986	cross sectional	community	self-rated decline	88	volunteers from retirement apartments and organizations		73.2
Bayer et al. 1987	cross sectional	clinical	depressive pseudodementia	100	memory clinic   		74.2
Erkinjuntti et al. 1987	Cross sectional	clinical	psychiatric disorders / pseudodementia	323	neurology outpatients with suspected dementia		50.4
Van der Cammen et al. 1987	cross sectional	clinical	pseudodementia due to an affective disorder	50	memory clinic 		75.2
Reynolds et al. 1988 a *2	cross sectional	clinical	depressive pseudodementia	14	patients with pseudodementia in MDD	28 dementia with depressive features	72.6 (75.1 DPD, 71.4 D)
Reynolds et al. 1988 b *2	cross sectional	clinical 	dementia syndrome of depression  	14	patients with pseudodementia	28 dementia with depressive features	70.9 (depressed 70.3, dementia 72.8, mixed 72.6, controls 69.3)
Brenner and Reynolds 1989	longitudinal	clinical	depressive pseudodementia 	33	patients with mixed symptoms of depression and dementia	35 AD without depression, 61 HC	73.2 (controls 67.6)
Derouesne et al. 1989	cross sectional	clinical	 'psychoactive brain dysfunction'	367	memory clinic		62.9
Kral and Emery 1989	longitudinal	clinical	depressive pseudodementia	44	patients diagnosed with depressive pseudodementia		76.5
Pearlson et al. 1989	cross sectional	clinical	dementia syndrome of depression; 'pseudodementia'	26	patients with dementia syndrome of depression	13 AD, 31 HC	69.8 (71.9 DOD, 70 depressed cognitively normal, 70.6 AD, 68.3 HC)
McGlone et al. 1990	cross sectional	clinical	memory complaints	57	patients referred by neurologists for neuropsychological assessment during screening for early dementia	35 HC	66.05 (65.6 patients (69.6 dementia, 61.5 non), 66.5 controls)
Brodaty 1990	cross sectional	clinical	psychiatric or 'normal / anxious personality'	144	memory clinic		69.5
Crook and Larrabee 1990	cross sectional	community	memory problems  	1103	volunteers recruited through the print and electronic media		56
O'Connor et al. 1990	cross sectional	community	memory complaints	384	>75 year olds from GP practice registers		60.2
Rabbitt and Abson 1990	cross sectional	community	memory self-report	442	volunteers		63
Sachdev et al. 1990*	longitudinal	clinical	pseudodementia (includes all psychiatric but depressive disorders most likely)	200	inpatients assessed in Smith 1981 who were diagnosed with pseudodementia		53
Bolla et al. 1991	cross sectional	community	memory complaints	199	volunteers through newspaper advertisements		62
Christensen et al. 1991	cross sectional	community	memory complaints	20	elderly volunteers to advertisement for subjects with 'memory problems'	11 HC	64.9
Gottlieb et al. 1991	cross sectional	clinical	pseudodementia	14	patients diagnosed with pseudodementia	24 HC	69
Weiner et al. 1991	cross sectional	clinical	depression, somatization disorder, dysthmic disorder	317	memory clinic 		not stated
Ames et al. 1992	cross sectional	clinical	functional psychiatric disorders and 'other'	100	memory clinic		75.5
Crook et al. 1992	cross sectional	clinical	memory complaints	232	individuals participating in a trial of experimental medication for AAMI		59.2
Dolan et al. 1992	cross sectional	clinical	primary psychiatric diagnoses	10	outpatients and inpatients with moderate to severe depression	10 depression without cognitive impairment	57.05 (60.9 impaired, 53.2 unimpaired)
O'Brien et al. 1992	longitudinal	clinical	benign senescent forgetfulness	64	memory clinic patients with 'benign senescent forgetfulness'		67.2
Taylor 1992 fos	longitudinal	community	subjective memory disorder	30	older adults with subjective memory decline (previous participants in short-term drug trial)		67.5
Almeida et al. 1993	cross sectional	clinical	memory complainers / no diagnosis (24%)	418	memory clinic		66.7
Flicker et al. 1993	longitudinal	community	SMI	59	dementia clinic patient family members and advertisement responders		68.7
Grut te al. 1993	cross sectional	community	memory complaints	614	all inhabitants of an area in Sweden		not stated
Spear-Bassett and Folstein 1993	cross sectional	community	memory complaints	810	Eastern Baltimore Mental Health Survey		not stated
Verhey 1993	cross sectional	clinical	not specified, depression, other psychiatric disorder	430	memory clinic 		61.7
Barker et al. 1994	cross sectional	clinical	memory complaints	49	memory clinic - GP and self-referred	41 HC	69
Hanninen et al. 1994	cross sectional	community	SMC	10	population-based dementia screening study	10 HC	72 (71.7 complainers, 71.5 non-complainers)
Jorm et al. 1994 *3	cross sectional	community	memory complaints	744	electoral roll sample of elderly people		range >70
Barker and Prior 1995 	cross sectional	clinical	memory complaints	24	patients self-referring to a memory clinic and non-presenting controls	24 HC	not stated
Mcpherson et al. 1995	cross sectional	community	memory problems  	25	first-degree relatives of patients with diagnosis of probable or definite AD enrolled in a study	26 HC without family history	60.4 (59.9 relatives, 61 controls)
Tobiansky et al. 1995	longitudinal	community	SMI	705	electoral ward sample		74.6
Wright and Lindesay 1995	cross sectional	clinical	not dementia	not stated	20 memory clinics across UK year prior to survey in 1993		not stated
Collins and Abeles 1996	cross sectional 	community	SMC	90	volunteers to advertisement to University Psychological Clinic Aging Research Project 		70.4
Kopelman and Crawford 1996	cross sectional	clinical	dx - psychiatric disorders, WW, psychogenic amnesia	200	memory clinic 		43.7
Lehmann et al. 1996	cross sectional	clinical	no cognitive disturbance	406	memory clinic 		62.9
Rue et al. 1996	cross sectional	community	subjective memory loss	61	1st degree relatives of AD 	41 HC without family history	61.3 (60.9 relatives, 61.9 controls)
Schmand et al. 1996 	longitudinal	community	SMC	357	population-based group without dementia or other psychiatric disorders at baseline		75.3
Smith et al. 1996	longitudinal	community	SMC	394	population-based older americans normative study		72.1
Swanwick et al. 1996	cross sectional	clinical	WW / not dementia	200	memory clinic 		74.3
Blazer et al. 1997	longitudinal	community	memory complaints	3080	Duke Established Populations for Epidemiologic Studies of the Elderly		72
Schmand et al. 1997 *4	longitudinal	community	SMC	3590	Amsterdam Study of the Elderly (AMSTEL) 		74.9
Schofield et al. 1997 	cross sectional	clinical	SMC	233	individuals from a register of individuals with possible cognitive impairment	131 no cognitive impairment	75.9 (74.2 no cognitive impairment, 77 cognitive impairment)
Braekhus et al. 1998	longitudinal	community	subjective worsening of memory	285	random sample older people		81.5
Levy-Cushraan and Abeles 1998	cross sectional	community	SMC	132	older adults - advertisement responders		67.6
Yousef et al. 1998	cross sectional	clinical	depressive pseudodementia	63	patients referred for psychogeriatric assessment with differential diagnosis of depressive pseudodementia	44 dementia, 19 dementia and depression	75.5
Derouesne et al. 1999	cross sectional	clinical	memory complaints	260	self-referral memory clinic		54.6
Geerlings et al. 1999 *4	longitudinal	community	memory complaints	3778	Amsterdam Study of the Elderly (AMSTEL) - 'nondemented persons 65-84 years old'		range 65-84
Hogh et al. 1999	cross sectional	clinical 	no psychiatric disease, depression, other psychiatric disease	400	memory clinic 		63.6
Clarnette et al. 2001	cross sectional	community	SMC	108	volunteers	38 HC	63
Cutler and Hodgson 2001	cross sectional	community	anticipatory dementia	108	adult children with living parent diagnosed with AD 	150 HC without family history	49.7 (50.0 adult children, 49.4 comparitors)
Jorm et al. 2001 *3	longitudinal	community	memory complaints	331	electoral roll sample of elderly people 		74.82
Small et al. 2001	cross sectional	community	SMC	66	participants in longitudinal study, recruited through advertisements and physician referral		63.7
Luce et al. 2001	cross sectional	clinical	SMI	200	memory clinic vs old age psychiatry clinic		68.9 vs 80.9
Elberling et al. 2002 *5 - subset of Hejl 2002	cross sectional	clinical	no cognitive deficits (including no neuropsychiatric disease, psychiatric disease)	314	memory clinic		47.6
Hejl et al. 2002 *5	cross sectional	clinical	no cognitive deficits, no neuropsychiatric disease	1000	memory clinic		66.1
St John and Montgomery 2002	longitudinal	community	subjective memory loss	1416	Manitoba Study of Health and Aging		75.3
Hejl et al. 2003	cross sectional	clinical	no cognitive deficits, no neuropsychiatric disease	100	memory clinic 		74.2
Lucas 2003	cross sectional	clinical	subjetive cognitive complaints	20	neurology outpatients		49.8
Zimprich et al. 2003	longitudinal	community	subjective cognitive complaints	427	participants in Interdisciplinary Study on Adult Development (ILSE)		62.9
Hepple 2004	case series	clinical	conversion pseudodementia	10	psychiatry inpatients with 'conversion pseudodementia'		66.6
Jungwirth et al. 2004	cross sectional	community	SMC	302	75 year olds from population register		75
van der Flier et al 2004 	cross sectional	clinical	SMC / memory complainers	28	self-referred memory complainers at memory clinic	20 HC	73.5 (72 complainers, 75 controls)
Larner 2005	cross sectional	clinical	absence of dementia	247	memory clinic 		not stated
Lautenschlager et al. 2005	cross sectional	community	SMC	264	community-dwelling women >70 recruited via advertisement		74.5 (HCG 74.3, SMC 74.7, 74.2 MCI)
Lehrner et al. 2005	longitudinal	clinical	subjective complaints and MCI	114	memory clinic patients with memory complaints NOT receiving dementia diagnosis and not <50		66.9
Minett et al. 2005	cross sectional	clinical	SMC	60	memory clinic patients without dementia		72.6
Pearman et al. 2005	cross sectional	community	SMC	85	volunteers		73.2
Wolf et al. 2005	cross sectional	community	SMC	46	research clinic volunteers		61.8
Zandi 2004	cross sectional	community	SCC	603	memory clinic patients		77.6
Archer et al. 2006	cross sectional	clinical	symptoms of memory impairment	58	subjects with symptoms of memory loss without obvious or treatable cause of impairment	33 HC	63.7 (controls 62.6, altogether 63.3)
Busse et al. 2006	longitudinal 	clinical	SCD and MCI 	980	LEILA 75+ (Leipzig Longitudinal Study of the Aged) participants without dementia		81.5
Prichep et al. 2006	longitudinal	community	subjective cognitive complaints	44	elderly volunteers with subjective cognitive complaints but no objective impairment (GDS stage 2)		72.14
Banerjee et al. 2007	cross sectional	clinical	no illness	247	memory clinic 		not stated
Glodzik-Sobanska et al. 2007	longitudinal	community	SMC	230	volunteers to study of ageing 		67
Jessen et al. 2007	cross sectional	community	SMI	2389	volunteers without cognitive impairment recruited randomly from GP registers 		80.2
Park et al. 2007	cross sectional	community	SMC	9477	population cohort recruited at flu vaccination		72.61
Saez-Fonseca et al. 2007	longitudinal	clinical	depressive pseudodementia	182	inpatients and day hospital patients with depressive pseudodementia		77.6
Sinforiani et al. 2007	cross sectional	clinical	SMC	74	memory clinic - all presenting with memory disturbances, not dementia		71.6
van Oijen et al. 2007	longitudinal	community	SMC	6927	Rotterdam Study		69.5
Ahmed et al. 2008	longitudinal	clinical 	SMC, 'worried well'	22	memory clinic	85 aMCI, 40 semantic dementia	67.44
Gainotti et al. 2008	cross sectional	clinical	depressive pseudo-dementia	26	patients with depressive pseudodementia	42 AD, 35 HC	65.8 (68.6 DPD, 67.8 AD, 61.3 HC)
Gallassi et al. 2008	cross sectional	clinical	SCC / SCI	92	outpatient with subjective cognitive complaints		67.4
Mendes et al. 2008	cross sectional	community	memory complaints	292	blood donors, unpaid helpers and relatives of patients at a hospital in Lisbon, volunteers attending universities. 		50.5
Schmitdke et al. 2008	longitudinal	clinical	functional memory disorder	73	probable non-organic cognitive impairment from memory clinic		55.2
Brucki and Nitrini 2009	cross sectional	community	SMI	163	rural population with low education in Amazon rainforest		62.3
Hancock and Larner 2009	cross sectional	clinical	memory complainers without dementia	310	memory clinic patients		66.9
Metternich et al. 2009	cross sectional	clinical	functional memory disorder	39	memory clinic - patients with FMD	38 HC	55
Ramakers et al. 2009	cross sectional	clinical	SMC	33	memory clinic patients with SMC	83 non-help seeking SMC in population study	64.2 (62 help-seekers, 65.1 non)
Schmitdke et al. 2009	cross sectional	clinical	functional memory disorder	86	patients with FMD	88 HC	52.9 (55.8 FMD, 50.1 controls)
Visser et al. 2009	longitudinal	clinical	SCI, naMCI, MCI	168	memory clinics (20 across europe) - patients with SCI, naMCI, aMCI	89 HC	68
Westoby et al. 2009	cross sectional	community	CC	7878	population from GP registers		66.3
Benito Leon et al. 2010	longitudinal	community	SMC	1073	population-based - SMC without dementia 	1073 HC	75.4
Che telat et al. 2010	cross sectional	community	SCI	49	SCI and MCI from Australian Imaging Biomarkers and Lifestyle Study of ageing	34 MCI, 35 AD, 45 HC	74.7
Elfgren et al. 2010 *6	longitudinal	clinical	SMC	59	memory clinic		59.6
Gino et al. 2010	cross sectional	community	SMC	946	volunteers attending health screening unit, blood donors, leisure centre, senior citizens college or university in Lisbon		54.2
Gucuyener et al. 2010	cross sectional	clinical	depressive pseudodementia	13	patients with depressive pseudodementia	11 AD, 10 HC	65.9 (66.2 AD, 65.4 DPD) and 63.9 HC
Kenfield et al. 2010	cross sectional	clinical	psychiatric disorders (most depression and anxiety), no neuropsychiatric disorder	109	behavioural neurology clinic patients		not stated (60.6 for the 109 with nonneurologic conditions)
Reisberg et al. 2010	longitudinal	community	SCI	166		47 no cognitive impairment	67.2
Slavin et al. 2010	cross sectional	community	SCC	827	electoral roll		63
Striepens et al. 2010	cross sectional	clinical	SMI	21	memory clinic patients with both subjective and informant-reported memory complaint, performing in normal ranges on  tests	48 HC	65.9 (66.3 SMI, 65.8 controls)
Vestberg 2010 *6	longidutinal	clinical	subjective memory symptoms	52	memory clinic 		57.5
Amariglio et al. 2011 	cross sectional	community	SMC	16964	women from the Nurses' Health Study		74
Aarts et al. 2011	cross sectional	community	SMC	15188	postal survey of residents of Netherland province		70
Cooper et al. 2011	cross sectional	community	subjective forgetfulness	7461	Adult Psychiatric Morbidity Survey		45
Hurt et al. 2011 *7	cross sectional	clinical	SMC	60	memory clinic patients subjective memory symptoms	38 non-help-seeking SMC	73.4
Mascherek et al. 2011	cross sectional	clinical	SCC	169	memory clinic patients referred by physician or relatives		76
Menon and Larner 2011 	cross sectional	clinical	not dementia	708	memory clinic 		not stated
Montejo et al. 2011 *8	cross sectional	community	SMC	1637	Madrid Health Survey		74.7
Paradise et al. 2011	cross sectional	community	SMC	45532	45 and Up Study (Australia cohort) 		range 45-64
Puetz et al. 2011	cross sectional	clinical	FMD	12	center for geriatric medicine and gerontology outpatients	12 HC	52.05
Rodda et al. 2011	cross sectional	clinical	subjective cognitive impairment	11	memory clinic patients with SCI	12 HC	68.5 (64.0 SCI, 73.5 control)
Wang et al. 2011	cross sectional	clinical	SCI,  neurosis	2789	memory clinic 		58% >70
Amariglio et al. 2012 	cross sectional	community	clinically normal	131	Harvard Aging Brain Study		73.5
Bartley et al. 2012	cross sectional	community	SMC	96	healthy subjects recruited through public awareness meetings and from relatives		61.8
Caracciolo et al. 2012	cross sectional	community	SCI	11926	Swedish twin register		not stated
Dolek et al. 2012	cross sectional	clinical	pseudodementia, AD, VD, MCI	16	patients presenting with memory loss to behavioural neurology clinic with pseudodementia	14VaD, 22 ATD, 12 MCI, 11 HC	69.4 (68.6 pseudodementia, 70.3 AD, 70.8 VD, 72.6 MCI, 63.9 HC)
Hurt et al. 2012 *7	cross sectional	clinical	SMC	60	memory clinic 	38 non-help-seeking SMC	73.4  (71.6 clinical, 76.1 community)
Montejo et al. 2012 *8	cross sectional	community	SMC	1937	Madrid Health Survey		74.67
Perrotin et al. 2012 	cross sectional	community	subjective cognition	48	cognitively normal elderly subjects		73.5
Sindi et al. 2012	cross sectional	community	SMC	40	Douglas Hospital Longitudinal Study of Normal and Pathological Ageing		71.25
Svendsen et al. 2012 	cross sectional	clinical	subjective complaints, MCI 	30	psychiatry outpatients: 15 bipolar disorer, 15 unipolar depression	15 HC	36.7 (34 BPAD, unipolar 41.0, control 35.1)
Apolinario et al. 2013	cross sectional	clinical	SCC	180	older patients attending memory clinic with subjective cognitive symptoms, exluding moderate dementia		74
Balash et al. 2013	cross sectional	community	SMC	636	volunteer or self-referral		68
Buckley et al. 2013	cross sectional	community	SMC	740	MCI and healthy adults from Australian Imaging Biomarkers and Lifestyle Study of Aging cohort		73.1
de Paula et al. 2013	cross sectional	clinical	depressive pseudodementia	34	patients with MDD, subjective and functional cognitive complaints and specific impairment but spared global function	62 HC	71.5 (70.21 DPD, 73.94 controls)
Genziani et al. 2013	cross sectional	community	SMI	9294	French community surveys ≥65		74.3
Ito et al. 2013	cross sectional	community	SMC	2034	community residents of Chiyoda ward, Tokyo		74.6
Kim et al. 2013	cross sectional	clinical	SMI	90	self-referrers to memory disorder clinic	28 HC	68.1 (65.8 patients, 70.7 controls)
Merema et al. 2013	cross sectional	community	MC	177	older adults - volunteers for memory study via newspaper advertisement 		73.62
Rienstra et al. 2013	cross sectional	clinical	MCI	170	patients with MCI		60.5
Rijs et al. 2013	longitudinal	community	SMC	962	Longitudinal Aging Study Amsterdam cohort 		60.2
Silva et al. 2013	longitudinal	clinical	cognitive complaints	250	Cognitive Complaints Cohort, Lisbon		69.1
Steinberg et al. 2013	cross sectional	community	SMC	125	U Penn AD centre 'normal control' cohort and outreach to residential independent living and other community-dwelling individuals		77
van Harten et al. 2013 'CSF AB42' 	longitudinal	clinical	SC	127	memory clinic 'nondemented patients with cognitive complaints' 		60
van Harten et al. 2013 'preclinical AD' 	longitudinal	clinical	SC	132	memory clinic patients with subjective complaints		61
Acikgoz et al. 2014	cross sectional	clinical	SMC	405	other outpatients		64.64
Begum et al. 2014	cross sectional	community	SMC and subjective concentration complaints	26091	English Psychiatric Morbidity population surveys 1993, 2000, 2007		42
Caselli et al. 2014	longitudinal	community	SCD	447	healthy members of Alizona APOE cohort 		59
Chen et al. 2014	cross sectional	community	SMI	18614	representative community sample via telephone survey		range 18-99
Chin et al. 2014	cross sectional	clinical	SMI	108	memory disorder clinic patients with complaints of memory decline but normal neuropsychological assessment		63.35
Garcia-Ptacek et al. 2014	cross sectional	clinical	SCI	993	memory clinic 		62.5
Larner 2014 *9	cross sectional	clinical	absence of dementia / 'cognitively healthy'	726	memory clinic		61
Lehrner et al. 2014	cross sectional	clinical	SMC	581	memory clinic patients with subjective memory complaints	248 HC	66.3 (66.4 SMC, 66.3 controls)
Lineweaver et al. 2014 	longitudinal	community	self-rated memory function	74	neurologically intact adults informed of APOE4 status	70 not informed	73.4
Mewton et al. 2014	cross sectional	community	SMC	1905	NSMHWB sample - population survey		range 65-85
Singh-Manoux et al. 2014	cross sectional	community	SCC	15510	French GAZEL study		57.9
Studer et al. 2014	cross sectional	clinical	SCD	55	patients with diagnosis of MCI	84 HC	67.8 (70.5 MCI, 66.3 controls)
Tomita et al. 2014	cross sectional	community	SMC	394	volunteers >60		68.7
Zlatar et al. 2014	cross sectional	community	cognitive complaints	1000	randomly selected adults from SAGE study of aging without diagnosis of dementia		77.3
Arbabi et al. 2015	cross sectional	clinical	SMC	90	memory clinic		52.31
Djukic et al. 2015	longitudinal	clinical	Depressive pseudodementia	166	geriatric medical inpatients		82.9
Elsey et al. 2015	cross sectional	clinical	FMD	15	memory clinic 	15 neurodegenerative disease	63 (60 FMD, 66 ND)
Hessen et al. 2015 *10	cross sectional	clinical	SCD	122	patients with SCD from 2 memory clinics (10% self-referrals) 		62.5
Kaup et al. 2015	longitudinal	community	SMC	1107	population cohort		70.8
Pennington et al. 2015	cross sectional 	clinical	FCD	196	memory clinic		not stated
Smart et al. 2015	cross sectional	community	SCD	17	community participants reporting SCD 	25 HC	69.7 (69.47 SCD, 69.88 HC)
Tomita et al. 2015	cross sectional	community	SMC	289	volunteers participating in the 'Iwaki Health Promotion Project' in 2013		68.4
Cavuoto 2016	cross sectional 	community	SMD	181			74
Claus et al. 2016	cross sectional	clinical	SCI + MCI	2000	memory clinic 		78.2
Eckerstrom et al. 2016 *11	cross sectional	clinical	SCI + MCI	90	memory clinic patients without dementia	160 MCI	62.3 (59.8  SCI, 63.7  MCI)
Handels et al. 2016	longitudinal	clinical	SMC + MCI	114	patients referred from 4 dutch university memory clinics with suspected cognitive disorder		67.3
Jones et al. 2016	cross sectional	clinical	FMD	16	memory clinic	9 neurodegenerative disease	[61 dementia, 60 FMD]
Jung et al. 2016	cross sectional	clinical	SMI	613	memory clinic attenders with subjective memory impairment	613 HC	64.9
Kinzer et al. 2016	cross sectional	community	SMC	100	volunteers responding to memory screening advertisements		69
Lee et al. 2016	longitudinal	community	SMC	3272	Midlife in the US Study surveys		56.48
Pedro et al. 2016 *8	cross sectional	community	SMC	1342	Madrid Health Survey		74.25
Roehr et al. 2016	longitudinal	community	SCD	453	Leipzig longitudinal study of the aged (LEILA75+)		80.5
Rowell et al. 2016	cross sectional	community	SMC	3798	healthy adults recruited from newspaper advertisements, excluded if cognitive impairment		51.16
Sierra-Rio et al. 2016 	longitudinal	clinical	SCD + MCI	149	outpatients with memory complaints not dementia 		67.5
Tanaka et al. 2016	cross sectional	community	SMC	556	twins ≥ 20 years		51
Vogel et al. 2016	cross sectional	clinical	SCD	121	memory clinic patients with mild cognitive symptoms 		69
Wolfsgruber et al. 2016	longitudinal	community	SCD	1990	cognitively normal participants in AgeCoDe study		80.1
Chu et al. 2017	cross sectional	clinical	SMC	113	older people >60 with a history of depression but not current depression		66.7
Eckerstrom et al. 2017 *11	longitudinal	clinical	SCD, SCD plus, MCI	122	memory clinic patients without dementia	113 MCI	64
Ferreira et al. 2017 	longitudinal	clinical and community	SMD	134	Australian Imaging Biomarkers and Lifestyle study of ageing: AD, MCI, healthy		73.4
Hessen et al. 2017 *10	longitudinal	clinical	SCD	81	2 memory clinics - patients with SCD		61
Hu et al. 2017	cross sectional	clinical	SCD	20	memory clinic patients with subjective cognitive decline 	24 HC	67.3 (68.3 SCD, 66.49 control)
Jansen et al. 2017 	longitudinal	clinical	SCI	221	patients from 4 Dutch memory clinics		66.6
Kang et al. 2017	cross sectional	community	SMC	459	population-based cohort  			68.2
Kuiper et al. 2017	longitudinal	community	SMC	8762	population-based sample (LifeLines cohort)		70
Markova et al. 2017	cross sectional	community	SCC	340	cognitively healthy volunteers		75
Mirheidari et al. 2017 	cross sectional	clinical	FMD	15	memory clinic patients with FMD	15 neurodegenerative disease	60.79 (63.78 ND, 57.8 FMD)
Mogle et al. 2017 	cross sectional 	community	subjective memory	3434	Midlife in the United States Study		56.1
Perrotin et al. 2017	cross sectional	clinical	SCD	28	memory clinic patients with SCD	25 non-presenting SCD, 35 HC	68 (67.6 (SCD clinic, 70.8 SCD community, 65.6 controls)
Sahin et al. 2017	cross sectional	clinical	depressive pseudodementia	35	patients with depressive pseudodementia	20 AD	72.2
Sakurai et al. 2017	longitudinal	community	SMC	496	local resident registration sample with no cognitive impairment >65		72.7
Schweizer et al. 2017	cross sectional	community	SMC	2544	population (Cam-CAN cohort)		59.5
Soysal et al. 2017	cross sectional	clinical	benign senescent forgetfulness	529	geriatrics outpatient clinic for memory complaints		75.7
Tandetnik et al. 2017	cross sectional	community	cognitive complaints	76	subjects with intact cognitive fx recruited through advertisment offering free participation in an SCD intervention		69.2
Yates et al. 2017	longitudinal	community	SMC	1344	older people in MRC-CFAS population-based study		74
Alexander et al. 2018 	cross sectional	clinical	FMD	17	outpatients at 'young onset' dementia service with FMD (excluding active depression)		not stated
Alves et al. 2018 	longitudinal	clinical	MC / MCI	66	patients with memory symptoms, not dementia		66.1
Amariglio et al. 2018 	longitudinal	community	SCC	279	population cohort		73.7
Avila-Villanueva 2018 	longitudinal	community	SCD	1091	population cohort		74.71
Bessi et al. 2018	longitudinal	clinical	SCD	212	memory clinic patients determined as having SCD or MCI		66.7
Bharambe et al. 2018 *12	cross sectional	clinical	FCD	89	memory clinic		62
Bharambe et al. 2018 *9	cross sectional	clinical	FCD	169	memory clinic 		60
Binnekade et al. 2018 	cross sectional	clinical  	SCI, MCI, dementia subtypes	759	memory clinic		79
Cespon et al. 2018 	cross sectional	community	SMC	34	population sample		64.9
Cosentino et al. 2018	cross sectional	community	SCD	471	population-based cohort 'North Manhattan Aging Project' (medicare beneficiaries aged 65 years and older)		72.8
Elhadd et al. 2018 *12	cross sectional	clinical	FCD	89	memory clinic 		[62]
Flatt et al. 2018	cross sectional	community	SCD	210	older (>50) LGBT adults from community centre		59.6
Haussman et al. 2018 a 	cross sectional	clinical	SMI, normal objective cognition	171	memory clinic		not stated
Haussmann et al. 2018 b 	cross sectional	clinical	SMI and MCI	35	memory clinic	40 HC	68.1 (70.3 MCI, 66.2 controls)
Hall et al. 2018	longitudinal	community	cognitive complaints	319	cognitively normal Mexican-American elderly people in HABLE cohort study		58.91
Hill 2018 14m	cross sectional	community	SMI	19	>60 with memory complaints 		80.7
Kambe et al. 2018 	cross sectional	clinical	MC	21	unaccompanied memory clinic patients	75 accompanied memory clinic attenders	80 (76.1 unaccompanied, 81.2 accompanied)
Larner 2018 	cross sectional	clinical	SMC	50	memory clinic 		[60.5]
Luck et al. 2018 	cross sectional	community 	SCS	8834	LIFE adult cohort		58.8
Lundholm Fors et al. 2018 	cross sectional	clinical	SCI and MCI	54	patients with mild and subjective cognitive impairment	36 HC	68.2 (SCI 66.3, MCI 70.1, HC 67.9)
Meyer et al. 2018 	cross sectional	community	SMC	600	stratified sample adults ≥ 55		70.3
Miley-Akerstedt et al. 2018 	cross sectional	clinical	SMC	209	memory clinic		58
Nunes et al. 2018	cross sectional	community	MC	59	final year medical students		25.7
Randall et al. 2018 	cross sectional	clinical	FCD	169	cognitive function clinic		[60]
Reuber et al. 2018	cross sectional	clinical	FMD	20	memory clinic - patients with FMD	20 neurodegenerative disease	60.7 (57.25 FMD, 64.2 ND)
Sanchez-Benzvides et al. 2018 	cross sectional	community	SCD	2670	cognitively healthy middle-aged first-degree descendents of AD patients 		55.8
Schweizer et al. 2018	cross sectional	community	SCD	2544	Cam-CAN cohort		59.8
Schwert et al. 2018	cross sectional	clinical	SCC + cognitive deficits in major depressive disorder	102	outpatients with major depressive disorder 	88 HC	42.8 (42.6 MDD, 43.1 HC)
Sheng et al. 2018 	cross sectional	clinical	normal cognition, 'reversible dementia' 	454	memory clinic 		76.1
Slot 2018 14m	cross sectional	clinical	SCD	151	patients with SCD  		64
Sorhabi 2018 14m	longitudinal	community	SMC	209	population cohort		64.6
Strand et al. 2018 	longitudinal	clinical	SCD	4682	norwegian register of persons assessed for cognitive symptoms (norcog)		77.1
Verity et al. 2018	cross sectional	clinical	worried well, cognitively normal	375	memory clinic		70.76
Wakefield et al. 2018	cross sectional	clinical	FMD	20	patients with a clinical diagnosis of FMD	20 aMCI, 20 HC	63.4 (FMD 60.5, aMCI 66.3, controls 63.4)
Wallert et al. 2018	cross sectional	clinical	SCI + MCI	120	patients referred for full neuropsychological assessment to memory clinic		76.9
Zlatar et al. 2018 	cross sectional	clinical	SCD	145	memory clinic referred with cognitive complaints with MMSE >24		74
Brailean et al. 2019 	longitudinal	community	SMC	11092	population cohort > 50		65.3
Gamaldo et al. 2019	cross sectional	community	SMC	351	African American older adults		72
Jenkins et al. 2019 	cross sectional	community	SCI  	99	memory clinic  		60.43
Kawagoe et al. 2019 	cross sectional	clinical	SMC	322	older adults (60-94) who had undergone rs-fMRI scans		69.5
Slot et al. 2019 	longitudinal	clinical and community	SCD	2978	individuals with SCD (community and memory clinic)	1391 HC	73 (71 SCD,77 controls) 
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Box 1: Functional cognitive disorders: definition and subtypes 

Definition
	One or more symptoms  of impaired cognitive function are present
	Clinical findings show evidence of internal inconsistency: with observed or measured function, or between different situations
	Symptoms or impairment are not better explained by another medical disorder, although may be comorbid with another medical disorder
	Symptoms or impairment cause clinically significant distress or impairment in social, occupational, or other important areas of function, or warrant medical evaluation

Proposed overlapping subtypes (after Stone et al 2015):
	Excessive attentional focus on ‘normal’ cognitive symptoms
	Health anxiety about dementia, with perceived cognitive deficit
	Isolated functional cognitive symptoms with or without impairment on cognitive tests
	Cognitive symptoms as part of anxiety or depression
	Cognitive symptoms in other functional disorders, e.g. functional neurological disorders (dissociative seizures, functional movement disorders), chronic fatigue syndrome and fibromyalgia (‘brain fog’)*
	Dissociative cognitive states (e.g. dissociative amnesia, fugue, Ganser syndrome)

*  not included in this review – see (Teodoro et al. 2018)

Box 2: 
Search strategy 
EMBASE, PsycINFO, MEDLINE
Search A: (((functional or dissociative or psychogenic or hysterical or conversion or medically unexplained or subjective) ADJ (memory or cognit* or cogniform) ADJ (impairment or disorder or decline or complain* or symptom*)) OR pseudodementia) AND (((memory or cognit* or cogniform) adj1 (symptom or complain* or subjective)) 
AND 
Search B: ((memory or cognit* or neurology or dementia) adj1 (clinic or outpatient)). Restricted to human, English language, NOT brain injury)
AND
Review of reference lists of included papers. 

duplicates removed
(n = 3,271)

title and abstracts screened 
(n = 2,386)

full texts screened
(n = 118) 

Search A

Search B 

n = 293

n = 175

n = 2,679

n = 5,950

PsychINFO
n = 162

MEDLINE
n = 173

EMBASE
n = 460

EMBASE
n = 2,710

MEDLINE
n = 1,177

PsychINFO
n = 1,268

studies identified from reference lists (n = 76)

n = 251
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